10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended

March 31, 2020

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-9576

O-I GLASS, INC.

(Exact name of registrant as specified in its charter)

Delaware	22-2781933
(State or other jurisdiction of	(IRS Employer
incorporation or organization)	Identification No.)

One Michael Owens Way, Perrysburg, Ohio	43551
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (567) 336-5000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol	Name of each exchange on which registered
Common Stock, $.01 par value	OI	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐	Non-accelerated filer ☐
Smaller reporting company ☐	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ The number of shares of common stock, par value $.01, of O-I Glass, Inc. outstanding as of March 31, 2020 was 156,571,353.

Part I — FINANCIAL INFORMATION

Item 1. Financial Statements.

The Condensed Consolidated Financial Statements of O-I Glass, Inc. (the “Company”) presented herein are unaudited but, in the opinion of management, reflect all adjustments necessary to present fairly such information for the periods and at the dates indicated. All adjustments are of a normal recurring nature. Because the following unaudited condensed consolidated financial statements have been prepared in accordance with Article 10 of Regulation S-X, they do not contain all information and footnotes normally contained in annual consolidated financial statements; accordingly, they should be read in conjunction with the Consolidated Financial Statements and notes thereto appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

The term “Company,” as used herein and unless otherwise stated or indicated by context, refers to Owens-Illinois, Inc. (“O-I”) prior to the Corporate Modernization (as defined in Note 10) and to O-I Glass, Inc. (“O-I Glass”) after the Corporate Modernization.

1

O-I GLASS, INC.

CONDENSED CONSOLIDATED RESULTS OF OPERATIONS

(Dollars in millions, except per share amounts)
(Unaudited)

	Three months ended
	March 31,
	2020		2019
Net sales	$	1,561	$	1,638
Cost of goods sold		(1,293)		(1,340)
Gross profit		268		298
Selling and administrative expense		(116)		(115)
Research, development and engineering expense		(16)		(16)
Interest expense, net		(53)		(65)
Equity earnings		15		19
Other expense, net		(17)		(10)
Earnings before income taxes		81		111
Provision for income taxes		(26)		(27)
Net earnings		55		84
Net earnings attributable to noncontrolling interests		(5)		(5)
Net earnings attributable to the Company	$	50	$	79
Basic earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51
Weighted average shares outstanding (thousands)		156,081		154,361
Diluted earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51
Weighted average diluted shares outstanding (thousands)		157,684		156,635

See accompanying notes.

2

O-I GLASS, INC.

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (LOSS)

(Dollars in millions)

(Unaudited)

	Three months ended
	March 31,
	2020		2019
Net earnings	$	55	$	84
Other comprehensive income (loss):
Foreign currency translation adjustments		(573)		49
Pension and other postretirement benefit adjustments, net of tax		31		6
Change in fair value of derivative instruments, net of tax		6		5
Other comprehensive income (loss)		(536)		60
Total comprehensive income (loss)		(481)		144
Comprehensive (income) loss attributable to noncontrolling interests		4		(8)
Comprehensive income (loss) attributable to the Company	$	(477)	$	136

See accompanying notes.

3

O-I GLASS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in millions)

(Unaudited)

	March 31,		December 31,		March 31,
	2020		2019		2019
Assets
Current assets:
Cash and cash equivalents	$	891	$	551	$	326
Trade receivables, net of allowance of $30 million, $32 million, and $34 million at March 31, 2020, December 31, 2019 and March 31, 2019		767		621		939
Inventories		1,047		1,045		1,038
Prepaid expenses and other current assets		257		271		276
Total current assets		2,962		2,488		2,579
Property, plant and equipment, net		2,987		3,273		3,074
Goodwill		1,773		1,934		2,507
Intangibles, net		312		371		394
Other assets		1,470		1,544		1,598
Total assets	$	9,504	$	9,610	$	10,152
Liabilities and Share owners’ equity
Current liabilities:
Accounts payable	$	1,025	$	1,276	$	1,065
Short-term loans and long-term debt due within one year		283		124		91
Current portion of asbestos-related liabilities						160
Other liabilities		516		595		544
Total current liabilities		1,824		1,995		1,860
Long-term debt		6,115		5,435		5,820
Asbestos-related liabilities				486		372
Paddock support agreement liability		471
Other long-term liabilities		1,018		1,130		1,090
Share owners' equity		76		564		1,010
Total liabilities and share owners' equity	$	9,504	$	9,610	$	10,152

See accompanying notes.

4

O-I GLASS, INC.

CONDENSED CONSOLIDATED CASH FLOWS

(Dollars in millions)

(Unaudited)

	Three months ended March 31,
	2020		2019
Cash flows from operating activities:
Net earnings	$	55	$	84
Non-cash charges
Depreciation and amortization		126		126
Pension expense		9		8
Cash payments
Pension contributions		(13)		(11)
Asbestos-related payments				(71)
Cash paid for restructuring activities		(8)		(15)
Change in components of working capital		(461)		(697)
Other, net (a)		(23)		(19)
Cash utilized in operating activities		(315)		(595)
Cash flows from investing activities:
Cash payments for property, plant and equipment		(120)		(121)
Contributions and advances to joint ventures				(15)
Net cash proceeds on disposal of assets				1
Deconsolidation of Paddock		(47)
Other		2
Cash utilized in investing activities		(165)		(135)
Cash flows from financing activities:
Changes in borrowings, net		859		589
Issuance of common stock and other		(2)		(3)
Treasury shares repurchased				(38)
Dividends paid		(8)		(8)
Cash provided by financing activities		849		540
Effect of exchange rate fluctuations on cash		(29)		4
Increase (Decrease) in cash		340		(186)
Cash at beginning of period		551		512
Cash at end of period	$	891	$	326

(a) Other, net includes other non-cash charges plus other changes in non-current assets and liabilities.

See accompanying notes.

5

O-I GLASS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Tabular data dollars in millions, except per share amounts

1. Segment Information

The Company has three reportable segments and three operating segments based on its geographic locations: Americas, Europe and Asia Pacific. These three segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, and certain equity investments. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.

The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations, as well as certain retained corporate costs. The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under U.S. GAAP and therefore does not purport to be an alternative to earnings before income taxes. Further, the Company's measure of segment operating profit may not be comparable to similarly titled measures of other companies.
​

Financial information for the three months ended March 31, 2020 and 2019 regarding the Company’s reportable segments is as follows:

	Three months ended March 31,
	2020		2019
Net sales:
Americas	$	831	$	881
Europe		576		596
Asia Pacific		145		151
Reportable segment totals		1,552		1,628
Other		9		10
Net sales	$	1,561	$	1,638

	Three months ended March 31,
	2020		2019
Segment operating profit:
Americas	$	103	$	113
Europe		61		79
Asia Pacific		5		8
Reportable segment totals		169		200
Items excluded from segment operating profit:
Retained corporate costs and other		(21)		(24)
Charge for deconsolidation of Paddock		(14)
Interest expense, net		(53)		(65)
Earnings before income taxes	$	81	$	111

6

Financial information regarding the Company’s total assets is as follows:

	March 31,		December 31,		March 31,
	2020		2019		2019
Total assets:
Americas	$	4,693	$	5,264	$	5,621
Europe		3,290		3,127		3,273
Asia Pacific		896		1,012		1,012
Reportable segment totals		8,879		9,403		9,906
Other		625		207		246
Consolidated totals	$	9,504	$	9,610	$	10,152

2. Revenue

Revenue is recognized at the point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Sales, value added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment.

For the three-month periods ended March 31, 2020 and March 31, 2019, the Company had no material bad debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Condensed Consolidated Balance Sheet. For the three-month periods ended March 31, 2020 and March 31, 2019, revenue recognized from prior periods (for example, due to changes in transaction price) was not material.

The following tables for the three months ended March 31, 2020 and 2019 disaggregates the Company’s revenue by customer end use:

	Three months ended March 31, 2020
	Americas		Europe		Asia Pacific		Total
Alcoholic beverages (beer, wine, spirits)	$	508	$	411	$	101	$	1,020
Food and other		189		105		24		318
Non-alcoholic beverages		134		60		20		214
Reportable segment totals	$	831	$	576	$	145	$	1,552
Other								9
Net sales							$	1,561
	Three months ended March 31, 2019
	Americas		Europe		Asia Pacific		Total
Alcoholic beverages (beer, wine, spirits)	$	564	$	432	$	109	$	1,105
Food and other		180		103		25		308
Non-alcoholic beverages		137		61		17		215
Reportable segment totals	$	881	$	596	$	151	$	1,628
Other								10
Net sales							$	1,638

7

3. Credit Losses

The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers that it sells them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.

At March 31, 2020, the Company reported $767 million of accounts receivable, net of allowances of $30 million. Changes in the allowance were not material for the three months ended March 31, 2020.

4. Inventories

Major classes of inventory at March 31, 2020, December 31, 2019 and March 31, 2019 are as follows:

	March 31,		December 31,		March 31,
	2020		2019		2019
Finished goods	$	884	$	872	$	868
Raw materials		121		128		126
Operating supplies		42		45		44
	$	1,047	$	1,045	$	1,038

5. Derivative Instruments

The Company has certain derivative assets and liabilities, which consist of natural gas forwards, foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Natural gas forward rates, foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs are observable in active markets over the terms of the instruments the Company holds, and, accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.

Commodity Forward Contracts Designated as Cash Flow Hedges

The Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows.

An unrecognized loss of $2 million at March 31, 2020, an unrecognized gain of $1 million at December 31, 2019 and an unrecognized gain of $3 million at March 31, 2019 related to the commodity forward contracts were included in Accumulated other comprehensive income (“Accumulated OCI”), and will be reclassified into earnings in the period when the commodity forward contracts expire.

8

Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments

The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies.

Cash Flow Hedges of Foreign Exchange Risk

The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency.  The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign exchange risk.

An unrecognized loss of $4 million at March 31, 2020, an unrecognized loss of less than $1 million at December 31, 2019 and an unrecognized loss of $11 million at March 31, 2019, related to these cross-currency swaps, were included in Accumulated OCI, and will be reclassified into earnings within the next twelve months.

Interest Rate Swaps Designated as Fair Value Hedges

The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. The Company’s fixed-to-variable interest rate swaps are accounted for as fair value hedges. The relevant terms of the swap agreements match the corresponding terms of the notes and therefore there is no hedge ineffectiveness. The Company recorded the net of the fair market values of the swaps as a long-term liability and short-term asset, along with a corresponding net decrease in the carrying value of the hedged debt.

Cash Flow Hedges of Interest Rate Risk

The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt.

An unrecognized loss of less than $1 million at March 31, 2020, an unrecognized loss of $1 million at December 31, 2019 and an unrecognized loss of less than $1 million at March 31, 2019 related to these interest rate swaps, were included in Accumulated OCI, and will be reclassified into earnings within the next twelve months.

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure.  

An unrecognized gain of $10 million at March 31, 2020, an unrecognized gain of $8 million at December 31, 2019 and an unrecognized gain of $7 million at March 31, 2019, related to these net investment hedges, were included in Accumulated OCI, and will be reclassified into earnings within the next twelve months.

9

Balance Sheet Classification

The following table shows the amount and classification (as noted above) of the Company’s derivatives at March 31, 2020, December 31, 2019 and March 31, 2019:

	Fair Value of						Fair Value of
	Hedge Assets						Hedge Liabilities
	March 31,		December 31,		March 31,		March 31,		December 31,		March 31,
	2020		2019		2019		2020		2019		2019
Derivatives designated as hedging instruments:
Commodity forward contracts (a)	$	—	$	1	$	3	$	2	$	—	$	—
Interest rate swaps - fair value hedges (b)		11		8		18				2
Cash flow hedges of foreign exchange risk (c)		66		25		18		4		21		4
Interest rate swaps - cash flow hedges (d)								2		1		1
Net investment hedges (e)		5		2		6						4
Total derivatives accounted for as hedges	$	82	$	36	$	45	$	8	$	24	$	9
Derivatives not designated as hedges:
Foreign exchange derivative contracts (f)		10		2		2		5		—		1
Total derivatives	$	92	$	38	$	47	$	13	$	24	$	10
Current	$	30	$	8	$	23	$	8	$	—	$	3
Noncurrent		62		30		24		5		24		7
Total derivatives	$	92	$	38	$	47	$	13	$	24	$	10

(a) The notional amounts of the commodity forward contracts were $12 million, $13 million and $20 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2020 for all three periods.

(b) The notional amounts of the interest rate swaps designated as fair value hedges were €725 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2025 for March 31, 2020 and December 31, 2019 and 2024 for March 31, 2019.

(c) The notional amounts of the cash flow hedges of foreign exchange risk were $1.424 billion at March 31, 2020 and December 31, 2019 and $797 million at March 31, 2019. The maximum maturity dates were in 2023 for all three periods.

(d) The notional amounts of the interest rate swaps designated as cash flow hedges were $105 million at March 31, 2020 and December 31, 2019 and $180 million at March 31, 2019, respectively. Maximum maturity dates were in 2020 for March 31, 2020 and December 31, 2019 and 2021 for March 31, 2019.

(e) The notional amounts of the net investment hedges were €160 million at March 31, 2020, December 31, 2019 and March 31, 2019. The maximum maturity dates were in 2020 for all three periods.

(f) The notional amounts of the foreign exchange derivative contracts were $306 million, $283 million and $625 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2021, 2019, and 2019 for March 31, 2020, December 31, 2019 and March 31, 2019, respectively.

10

	Gain (Loss) Recognized in OCI (Effective Portion)				Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1)
	Three months ended March 31,				Three months ended March 31,
Derivatives designated as hedging instruments:	2020		2019		2020		2019
Cash Flow Hedges
Commodity forward contracts (a)	$	(3)	$	2	$	—	$	—
Cash flow hedges of foreign exchange risk (b)		(66)		7		60		(10)
Cash flow hedges of interest rate risk (c)
Net Investment Hedges
Net Investment Hedges		(4)		5		2		(2)
	$	(73)	$	14	$	62	$	(12)
	Amount of Gain (Loss) Recognized in Other income (expense), net
	Three months ended March 31,
Derivatives not designated as hedges:	2020		2019
Foreign exchange derivative contracts	$	12	$	6
(1) Gains and losses reclassified from accumulated OCI and recognized in income are recorded to (a) cost of goods sold, (b) other expense, net or (c) interest expense, net.

6. Restructuring Accruals

Selected information related to the restructuring accruals for the three months ended March 31, 2020 and 2019 is as follows:

	Employee		Other		Total
	Costs		Exit Costs		Restructuring
Balance at January 1, 2020	$	32	$	13	$	45
Net cash paid, principally severance and related benefits		(8)				(8)
Other, including foreign exchange translation		(2)		(1)		(3)
Balance at March 31, 2020	$	22	$	12	$	34

	Employee		Other		Total
	Costs		Exit Costs		Restructuring
Balance at January 1, 2019	$	47	$	22	$	69
Net cash paid, principally severance and related benefits		(13)		(2)		(15)
Other, including foreign exchange translation				(1)		(1)
Balance at March 31, 2019	$	34	$	19	$	53

When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the on-going operations of the business. Information related to major programs is presented separately while minor initiatives are presented on a combined basis. As of March 31, 2020 and 2019, no major restructuring programs were in effect.

For the three months ended March 31, 2020 and 2019, the Company has paid severance and related benefits along with other exit costs that were associated with past restructuring actions. The Company expects that the majority of the

11

remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years.

7. Pension Benefit Plans

The components of the net periodic pension cost for the three months ended March 31, 2020 and 2019 are as follows:

	U.S.				Non-U.S.
	2020		2019		2020		2019
Service cost	$	3	$	3	$	3	$	3
Interest cost		12		15		7		8
Expected asset return		(21)		(22)		(12)		(12)
Amortization of actuarial loss		14		10		3		3
Net periodic pension cost	$	8	$	6	$	1	$	2

8. Income Taxes

The Company calculates its interim tax provision using the estimated annual effective tax rate (“EAETR”) methodology in accordance with ASC 740-270. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income or loss in each tax jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the quarter they occur in accordance with GAAP. Depending on various factors such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. The Company’s annual effective tax rate may be affected by the mix of earnings in the U.S. and foreign jurisdictions and such factors as changes in tax laws, tax rates or regulations, changes in business, changing interpretation of existing tax laws or regulations, the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions. The annual effective tax rate differs from the statutory U.S. Federal tax rate of 21% primarily because of varying non-U.S. tax rates.

The Company is currently under examination in various tax jurisdictions in which it operates, including Bolivia, Brazil, Canada, Colombia, France, Germany, Indonesia and Peru. The years under examination range from 2004 through 2018. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies such as appeals and litigation, if necessary. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s results of operations, financial position or cash flows.

On March 27, 2020, the President of the United States signed the Coronavirus Aid, Relief, and Economic Security (CARES) Act into law. The CARES Act is an emergency economic stimulus package in response to the coronavirus outbreak that provides numerous tax provisions and other stimulus measures. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Some international jurisdictions in which the Company operates have also enacted legislation to provide economic stimulus in response to the coronavirus outbreak. The Company anticipates it may benefit from the ability to defer U.S. social security payroll tax that would otherwise be required in 2020, the acceleration of alternative minimum tax credit refunds, and potentially other provisions within the CARES Act. In addition, the Company may benefit from the deferral of certain non-U.S. tax payments to a future period. The Company expects the CARES Act and international legislation will not have a material impact on the Company’s condensed consolidated financial statements.

12

9. Debt

The following table summarizes the long-term debt of the Company:

	March 31,		December 31,		March 31,
	2020		2019		2019
Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans	$	817	$	—	$	—
Term Loans:
Term Loan A		1,477		1,477
Previous Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans						553
Term Loans:
Term Loan A						897
Other secured debt		330		333		504
Senior Notes:
6.75%, due 2020 (€500 million)						560
4.875%, due 2021 (€118 million at March 31, 2020 and December 31, 2019 and €330 million at March 31, 2019)		130		132		369
5.00%, due 2022		497		497		497
4.00%, due 2023		307		307		307
5.875%, due 2023		689		689		688
3.125%, due 2024 (€725 million)		813		824		824
6.375%, due 2025		296		295		296
5.375%, due 2025		297		297		298
2.875%, due 2025 (€500 million)		543		552
Finance leases		84		70		43
Other		13		11		18
Total long-term debt		6,293		5,484		5,854
Less amounts due within one year		178		49		34
Long-term debt	$	6,115	$	5,435	$	5,820

The Company presents debt issuance costs in the balance sheet as a deduction of the carrying amount of the related debt liability.

On June 25, 2019, certain of the Company’s subsidiaries entered into a new Senior Secured Credit Facility Agreement (as amended by that certain Amendment No. 1 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 13, 2019, and as further amended by that certain Amendment No. 2 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 19, 2019, the “Agreement”), which amended and restated the previous credit agreement (the “Previous Agreement”). The proceeds from the Agreement were used to repay all outstanding amounts under the Previous Agreement.

The Agreement provides for up to $3.0 billion of borrowings pursuant to term loans and revolving credit facilities. The term loans mature, and the revolving credit facilities terminate, in June 2024. At March 31, 2020, the Agreement includes a $300 million revolving credit facility, a $1.2 billion multicurrency revolving credit facility, and a $1.5 billion term loan A facility ($1,477 million net of debt issuance costs). At March 31, 2020, the Company had unused credit of $673 million available under the Agreement. The weighted average interest rate on borrowings outstanding under the Agreement at March 31, 2020 was 2.28%.

The Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within

13

guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.

The Agreement also contains one financial maintenance covenant, a Total Leverage Ratio (the “Leverage Ratio”), that requires the Company not to exceed a ratio of 5.0x calculated by dividing consolidated total debt, less cash and cash equivalents, by Consolidated EBITDA, with such Leverage Ratio decreasing to (a) 4.75x for the quarter ending June 30, 2021 and (b) 4.50x for the quarter ending December 31, 2021 and thereafter, as defined and described in the Agreement. The maximum Leverage Ratio is subject to an increase of 0.5x for (i) any fiscal quarter during which certain qualifying acquisitions (as specified in the Agreement) are consummated and (ii) the following three fiscal quarters, provided that the Leverage Ratio shall not exceed 5.0x. The Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Leverage Ratio to exceed the specified maximum.

Failure to comply with these covenants and other customary restrictions could result in an event of default under the Agreement. In such an event, the Company could not request borrowings under the revolving facilities, and all amounts outstanding under the Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Agreement. If an event of default occurs under the Agreement and the lenders cause all of the outstanding debt obligations under the Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of March 31, 2020, the Company was in compliance with all covenants and restrictions in the Agreement.  In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Agreement will not be adversely affected by the covenants and restrictions.

The Leverage Ratio also determines pricing under the Agreement. The interest rate on borrowings under the Agreement is, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Agreement, plus an applicable margin. The applicable margin is linked to the Leverage Ratio. The margins range from 1.00% to 1.50% for Eurocurrency Loans and from 0.00% to 0.50% for Base Rate Loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Leverage Ratio.

Obligations under the Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Agreement are guaranteed by certain foreign subsidiaries of the Company.

In July 2019, the Company redeemed €250 million aggregate principal amount of its outstanding 6.75% senior notes due 2020. The redemption was funded with cash on hand and revolver borrowings.

In November 2019, the Company issued €500 million aggregate principal amount of new senior notes. The new senior notes bear interest at a rate of 2.875% per annum and mature on February 15, 2025. The new senior notes were issued via a private placement and are guaranteed by certain of the Company’s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately €492 million and were used to redeem the remaining €250 million aggregate principal amount of the Company’s outstanding 6.75% senior notes due 2020 and approximately €212 million aggregate principal amount of the Company’s outstanding 4.875% senior notes due 2021.

In December 2019, subsidiaries of the Company completed consent solicitations to amend and waive certain provisions of the indentures governing certain of their senior notes. On December 11, 2019, those subsidiaries entered into supplemental indentures reflecting the amendments and waivers, which were obtained to facilitate the implementation of the Corporate Modernization.

14

In order to maintain a capital structure containing appropriate amounts of fixed and floating-rate debt, the Company has entered into a series of interest rate swap agreements. These interest rate swap agreements were accounted for as either fair value hedges or cash flow hedges (see Note 5 for more information).

The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.

The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy. Fair values at March 31, 2020 of the Company’s significant fixed rate debt obligations are as follows:

	Principal		Indicated
	Amount		Market Price		Fair Value
Senior Notes:
4.875%, due 2021 (€118 million)		130		99.96		130
5.00%, due 2022		500		100.96		505
5.875%, due 2023		700		91.81		643
4.00%, due 2023		310		95.00		295
3.125%, due 2024 (€725 million)		798		94.82		757
6.375%, due 2025		300		88.71		266
5.375%, due 2025		300		94.91		285
2.875%, due 2025 (€500 million)		551		93.20		513

10. Contingencies

Asbestos

From 1948 to 1958, one of the Company's former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos. The Company sold its insulation business unit in April 1958. The Company historically received claims from individuals alleging bodily injury and death as a result of exposure to asbestos from this product (“Asbestos Claims”). Some Asbestos Claims were brought as personal injury lawsuits that typically allege various theories of liability, including negligence, gross negligence and strict liability and seek compensatory and, in some cases, punitive damages.

Predominantly, however, Asbestos Claims were historically presented to the Company under administrative claims-handling agreements, which the Company had in place with many plaintiffs’ counsel throughout the country (“Administrative Claims”). Administrative Claims required evaluation and negotiation regarding whether particular claimants qualify under the criteria established by the related claims-handling agreements. The criteria for Administrative Claims included verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company's former business unit during its manufacturing period ending in 1958. Plaintiffs’ counsel presented, and the Company negotiated, Administrative Claims under these various agreements in differing quantities, at different times, and under a variety of conditions.

On December 26 and 27, 2019, the Company implemented the Corporate Modernization (“Corporate Modernization”), whereby O-I Glass became the new parent entity with Owens-Illinois Group, Inc. (“O-I Group”) and Paddock Enterprises, LLC (“Paddock”) as direct, wholly owned subsidiaries, with Paddock as the successor-by-merger to O-I. The Company’s legacy asbestos-related liabilities remained within Paddock, structurally separating them from the Company’s glass-making operations, which remain under O-I Group.

On January 6, 2020 (the “Petition Date”), Paddock voluntarily filed for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware to equitably and finally resolve all of its current and future asbestos-related claims. O-I Glass and O-I Group were not included in the Chapter 11 filing. As a result of the initiation of the Chapter 11 proceeding, Paddock now operates in the ordinary course under court protection from asbestos claims by operation of the automatic stay in Paddock’s Chapter 11 filing, which stays ongoing litigation and submission of claims against Paddock as of the Petition Date and defers the payment of Paddock’s outstanding

15

obligations on account of settled or otherwise determined lawsuits and claims. The bankruptcy process is expected to provide a centralized forum to resolve presently pending and anticipated future lawsuits and claims associated with asbestos. Paddock’s ultimate goal in its Chapter 11 case is to confirm a plan of reorganization under Section 524(g) of the Bankruptcy Code and utilize this specialized provision to establish a trust that will address all current and future asbestos-related claims. Because the Chapter 11 proceedings are in the early stages, it is not possible to predict the form of the ultimate resolution or when an ultimate resolution might occur.

As part of the Corporate Modernization transactions, O-I Glass entered into a support agreement with Paddock that requires O-I Glass to provide funding to Paddock for all permitted uses, subject to the terms of the support agreement. The key objectives of the support agreement are to ensure that Paddock has the ability to fund the costs and expenses of managing the Chapter 11 process, ultimately settle Asbestos Claims through the establishment of a trust as described above and fund certain other liabilities including applicable taxes. The ultimate amount that may be required to fund the trust in connection with a confirmed Chapter 11 plan of reorganization cannot be estimated with certainty.

Following the Chapter 11 filing, the activities of Paddock are now subject to review and oversight by the bankruptcy court. As a result, the Company no longer has exclusive control over Paddock’s activities during the Chapter 11 proceedings. Therefore, Paddock was deconsolidated as of the Petition Date, and its assets and liabilities, which primarily included $47 million of cash, the legacy asbestos-related liabilities, as well as certain other assets and liabilities, were derecognized from the Company’s consolidated financial statements on a prospective basis. Simultaneously, the Company recognized a liability related to the support agreement, as described above, of $471 million as required under applicable accounting standards, which may be subject to change based on the facts and circumstances of the Chapter 11 proceedings. Taken together, these transactions resulted in a loss of approximately $14 million, which was reflected as a charge in the Company’s first quarter 2020 operating results. Additionally, the deconsolidation resulted in an investing outflow of $47 million in the Company’s first quarter 2020 consolidated cash flows.

Several risks and uncertainties related to Paddock’s Chapter 11 case could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows, including the ultimate amounts necessary to fund any trust established pursuant to Section 524(g) of the Bankruptcy Code, the potential for the Company’s asbestos-related exposure to extend beyond Paddock based on corporate veil piercing efforts or other claims by asbestos plaintiffs, the costs of the Chapter 11 proceedings and the length of time necessary to resolve the case, either through settlement or various court proceedings, and the possibility that Paddock will be unsuccessful in attaining the desired relief under Chapter 11.

Prior to the Petition Date, the Company knew of approximately 850 asbestos lawsuits pending. This figure does not include an estimate of potential Administrative Claims that could have been presented under a claims-handling agreement due to the uncertainties around presentation timing, quantities, or qualification rates. The Company historically considered Administrative Claims to be filed and disposed of when they are accepted for payment.

The lack of uniform rules in lawsuit pleading practice, technical pleading requirement in some jurisdictions, local rules, and other factors caused considerable variation in the specific amounts of monetary damages asserted in lawsuits brought prior to the Petition Date. In the Company’s experience, the monetary relief alleged in a lawsuit bore little relationship to an Asbestos Claim’s merits or its disposition value. Rather, several variables, including but not limited to, the type and severity of the asbestos disease, medical history, and exposure to other disease-causing agents; the product identification evidence against the Company and other co-defendants; the defenses available to the Company and other co-defendants; the specific jurisdiction in which the claim was made; the applicable law; and the law firm representing the claimant, affected the value.

The Company was also a defendant in other Asbestos Claims involving maritime workers, medical monitoring, co-defendants’ third-party actions, and property damage allegations. Based upon its experience, the Company assessed that these categories of Asbestos Claims would not involve any material liability. Therefore, they were not included in the description of pending or disposed matters.

From receipt of its first Asbestos Claim to the Petition Date, the Company in the aggregate disposed of approximately 401,200 Asbestos Claims at an average indemnity payment of approximately $10,200 per claim. The Company’s asbestos indemnity payments varied on a per-claim basis. Asbestos-related cash payments for 2019 were $151 million and the Company’s cash payments per claim disposed (inclusive of legal costs) were approximately $129,000 for the year ended December 31, 2019.

16

Prior to the Petition Date, the Company’s objective was historically to achieve, where possible, resolution of Asbestos Claims pursuant to claims-handling agreements. Failure of claimants to meet certain medical and product exposure criteria in claims-handling agreements generally reduced the number of claims that would otherwise have been received by the Company in the tort system. In addition, changes in jurisdictional dynamics, legislative acts, asbestos docket management and procedures, the substantive law, the co-defendant pool, and other external factors affected lawsuit volume, claim volume, qualification rates, claim values, and related matters. Collectively, these variables generally had the effect of increasing the Company’s per-claim average indemnity payment over time.

Beginning with the initial liability of $975 million established in 1993, the Company accrued a total of approximately $5.0 billion through just prior to the Petition Date, before insurance recoveries, for its asbestos-related liability. The Company’s estimates of its liability were significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that filed for bankruptcy, changes in mortality rates, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the significant expansion of the types of defendants sued in this litigation, and changes in the extent to which such defendants participated in the resolution of cases in which the Company was also a defendant.

Prior to the Petition Date, the Company continually monitored trends that could affect its ultimate liability and analyzed the developments and variables likely to affect the resolution of Asbestos Claims. The material components of the Company’s total accrued liability were determined by the Company in connection with its annual comprehensive legal review and consisted of the following estimates, to the extent it was probable that such liabilities had been incurred and could be reasonably estimated: (i) the liability for Asbestos Claims already asserted against the Company; (ii) the liability for Asbestos Claims not yet asserted against the Company; and (iii) the legal defense costs estimated to be incurred in connection with the Asbestos Claims already asserted and those Asbestos Claims the Company believed would be asserted.

Through December 31, 2019, the Company historically conducted an annual comprehensive legal review of its asbestos-related liabilities and costs in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments have warranted an earlier review. As part of its annual comprehensive legal review, the Company provided historical Asbestos Claims data to a third party with expertise in determining the impact of disease incidence and mortality on future filing trends to develop information to assist the Company in estimating the total number of future Asbestos Claims likely to be asserted against the Company. The Company used this estimate, along with an estimation of disposition costs and related legal costs, as inputs to develop its best estimate of its total probable liability. If the results of the annual comprehensive legal review indicated that the existing amount of the accrued liability was lower (higher) than its reasonably estimable asbestos-related costs, then the Company recorded an appropriate charge (credit) to the Company’s results of operations to increase (decrease) the accrued liability.

The significant assumptions underlying the material components of the Company’s accrual historically were:

a) settlements would continue to be limited almost exclusively to claimants who were exposed to the Company’s asbestos containing insulation prior to its exit from that business in 1958;

b) Asbestos Claims would continue to be resolved primarily under the Company’s administrative claims-handling agreements or on terms comparable to those set forth in those agreements;

c) the incidence of serious asbestos-related disease cases and claiming patterns against the Company for such cases would not change materially, including claiming pattern changes driven by changes in the law, procedure, or expansion of judicial resources in jurisdictions where the Company settles Asbestos Claims;

d) the Company would be substantially able to defend itself successfully at trial and on appeal;

e) the number and timing of additional co-defendant bankruptcies would not change significantly the assets available to participate in the resolution of cases in which the Company is a defendant; and

f) co-defendants with substantial resources and assets would continue to participate significantly in the resolution of future Asbestos Claims.

For the year ended December 31, 2019, the Company concluded that an accrual in the amount of $486 million was required under applicable accounting standards. This amount has not been discounted for the time value of money. The Company’s comprehensive legal review resulted in a charge of $35 million the year ended December 31, 2019. As

17

previously disclosed, the Company anticipated that adjustments to its asbestos-related accruals were possible given the inherent uncertainties involved in asbestos litigation. In the fourth quarter of 2019, this charge was primarily due to an increase in the estimated average disposition cost per claim (including related legal costs), driven primarily by a changing litigation environment more favorable to plaintiffs, and an decrease in the estimated number of claims likely to be asserted against the Company in the future that was less than the decrease expected by the company.

Other Matters

Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

11. Share Owners’ Equity

The activity in share owners’ equity for the three months ended March 31, 2020 and 2019 is as follows:

	Share Owners’ Equity of the Company
									Accumulated
			Capital in						Other		Non-		Total Share
	Common		Excess of		Treasury		Retained		Comprehensive		controlling		Owners'
	Stock		Par Value		Stock		Earnings (Loss)		Loss		Interests		Equity
Balance on January 1, 2020	$	2		3,130		(733)		(89)		(1,843)		97	$	564
Reissuance of common stock (0.2 million shares)				(3)		5								2
Stock compensation (0.8 million shares)				1										1
Net earnings								50				5		55
Other comprehensive loss										(527)		(9)		(536)
Dividends declared								(8)						(8)
Other						(2)								(2)
Balance on March 31, 2020	$	2	$	3,128	$	(730)	$	(47)	$	(2,370)	$	93	$	76

	Share Owners’ Equity of the Company
									Accumulated
			Capital in						Other		Non-		Total Share
	Common		Excess of		Treasury		Retained		Comprehensive		controlling		Owners'
	Stock		Par Value		Stock		Earnings		Loss		Interests		Equity
Balance on January 1, 2019	$	2		3,124		(705)		333		(1,968)		114	$	900
Reissuance of common stock (0.1 million shares)				2		3								5
Treasury shares purchased (2.1 million shares)						(38)								(38)
Stock compensation (0.5 million shares)				4										4
Net earnings								79				5		84
Other comprehensive income (loss)										57		3		60
Other						(5)								(5)
Balance on March 31, 2019	$	2	$	3,130	$	(745)	$	412	$	(1,911)	$	122	$	1,010

18

The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:

	Shares Outstanding (in thousands)
	March 31,	December 31,	March 31,
	2020	2019	2019
Shares of common stock issued (including treasury shares)	189,210	188,447	188,348
Treasury shares	32,639	32,573	33,117

12. Accumulated Other Comprehensive Loss

The activity in accumulated other comprehensive loss for the three months ended March 31, 2020 and 2019 is as follows:

									Total
									Accumulated
	Net Effect of		Change in Certain						Other
	Exchange Rate		Derivative			Employee			Comprehensive
	Fluctuations		Instruments			Benefit Plans			Loss
Balance on January 1, 2020	$	(813)	$	(14)		$	(1,016)		$	(1,843)
Change before reclassifications		(564)		(2)			(2)			(568)
Amounts reclassified from accumulated other comprehensive income (loss)				11	(a)		17	(b)		28
Translation effect				(1)			16			15
Tax effect				(2)						(2)
Other comprehensive income (loss) attributable to the Company		(564)		6			31			(527)
Balance on March 31, 2020	$	(1,377)	$	(8)		$	(985)		$	(2,370)

									Total
									Accumulated
	Net Effect of		Change in Certain						Other
	Exchange Rate		Derivative			Employee			Comprehensive
	Fluctuations		Instruments			Benefit Plans			Loss
Balance on January 1, 2019	$	(889)	$	(18)		$	(1,061)		$	(1,968)
Change before reclassifications		46		(2)			(2)			42
Amounts reclassified from accumulated other comprehensive income (loss)				3	(a)		13	(b)		16
Translation effect				2			(5)			(3)
Tax effect				2						2
Other comprehensive income (loss) attributable to the Company		46		5			6			57
Balance on March 31, 2019	$	(843)	$	(13)		$	(1,055)		$	(1,911)

(a) Amount is included in Cost of goods sold and Other expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information).

(b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net postretirement benefit cost.

19

13. Other Expense, Net

Other expense (income), net for the three months ended March 31, 2020 and 2019 included the following:

	Three months ended March 31,
	2020		2019
Charge for deconsolidation of Paddock (see Note 10)	$	14	$	—
Foreign currency exchange loss				3
Intangible amortization expense		10		10
Royalty income		(4)		(3)
Other expense (income), net		(3)		—
	$	17	$	10

14. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:

	Three months ended March 31,
	2020		2019
Numerator:
Net earnings attributable to the Company	$	50	$	79
Denominator (in thousands):
Denominator for basic earnings per share-weighted average shares outstanding		156,081		154,361
Effect of dilutive securities:
Stock options and other		1,603		2,274
Denominator for diluted earnings per share-adjusted weighted average shares outstanding		157,684		156,635
Basic earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51
Diluted earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51

Options to purchase 2,533,717 and 1,496,298 weighted average shares of common stock, which were outstanding during the three months March 31, 2020 and 2019, respectively, were not included in the computation of diluted earnings per share because the options exercise price was greater than the average market price of the common shares.

15. Supplemental Cash Flow Information

Income taxes paid (received) in cash were as follows:

	Three months ended March 31,
	2020		2019
U.S.	$	2	$	(7)
Non-U.S.		32		33
Total income taxes paid in cash	$	34	$	26

Interest paid in cash for the three months ended March 31, 2020 and 2019 was $58 million and $70 million, respectively.

The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. At March 31, 2020, December 31, 2019 and March 31, 2019, the amount of receivables sold by the Company was $429 million, $539 million and $303 million, respectively. For the three months ended March 31, 2020 and 2019, the Company reduced the use of its factoring programs compared to the most recent respective year-end periods and this resulted in a higher use of working capital, and corresponding decrease to cash from operating activities, of approximately $110 million and $297 million, respectively.

20

16. New Accounting Pronouncement

Credit Losses - Effective January 1, 2020, the Company adopted ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The adoption of ASU No. 2016-13 had no cumulative effect adjustment as of January 1, 2020 and no material impact on the Company’s consolidated balance sheet, consolidated results of operations or consolidated cash flows. See Note 3 for additional information.
​

Disclosure Requirements for Fair Value Measurement - In August 2018, the FASB issued ASU No. 2018-13, “Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement” which modifies the fair value disclosure requirements. Application of the standard is required for annual periods beginning after December 15, 2019. The Company adopted this standard in the first quarter of 2020. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

Disclosure Requirements for Defined Benefit Plans - In August 2018, the FASB issued ASU No. 2018-14, “Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans” which modifies the defined benefit plan disclosure requirements. Application of the standard is required for annual periods beginning after December 15, 2020. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.

17. Business Combinations

On June 28, 2019, the Company completed the acquisition of Nueva Fábrica Nacional de Vidrio, S. de R.L. de C.V. (“Nueva Fanal”) from Grupo Modelo, an affiliate of Anheuser-Busch InBev SA/NV for a total purchase price of approximately $188 million. The Company financed this acquisition with debt. The Nueva Fanal facility is located near Mexico City, Mexico. Currently, this plant has three furnaces to produce and supply approximately 240,000 tons of glass containers annually for Grupo Modelo brands, such as Corona, for local and global export markets. This acquisition increases the Company’s presence in the Mexican glass packaging market.

Nueva Fanal’s operating results are included in the Company’s Consolidated Financial Statements from the acquisition date as part of the Americas segment. The acquisition qualifies as a business combination and will be accounted for using the acquisition method of accounting.

The total purchase price will be allocated to the tangible and identifiable intangible assets and liabilities based upon their respective fair values. The aggregate purchase price was preliminarily allocated to the Company’s balance sheet as of March 31, 2020, and has not yet been finalized because the Company has not yet completed the valuation of the acquired property, plant and equipment and the related depreciation periods. The Company expects that the purchase price allocation process will be completed no later than the second quarter of 2020. The following table summarizes the preliminary estimates of fair value of the assets acquired and liabilities assumed on June 28, 2019 and subsequent adjustments identified through the ongoing purchase price allocation process and recorded through the measurement period:

21

		June 28, 2019		Measurement Period Adjustments		March 31, 2020
Accounts receivable	$	42	$	—	$	42
Inventory		17				17
Goodwill				18		18
Intangibles		35		(32)		3
Net property, plant and equipment		129		32		161
Total assets acquired		223		18		241
Accounts payable		25		1		26
Accrued liabilities		3		(1)		2
Deferred tax liabilities				25		25
Net assets acquired	$	195	$	(7)	$	188

This acquisition did not meet the thresholds for a significant acquisition and therefore no pro forma financial information is presented.

18. COVID-19 Impacts

On March 11, 2020, the World Health Organization characterized the outbreak of the coronavirus disease, known as COVID-19, as a global pandemic and recommended containment and mitigation measures. The Company is actively monitoring the impact of the coronavirus global pandemic, which will negatively impact its business and results of operations for the second quarter of 2020 and likely beyond.  The extent to which the Company’s operations will be impacted by the global pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the global pandemic and actions by government authorities to contain the global pandemic or treat its impact, among other things.

Future changes in the Company’s cost of capital, expected cash flows, or other factors as a result of the above may cause the Company’s long-lived assets including goodwill to be impaired, resulting in a non-cash charge against results of operations to write down long-lived assets including goodwill for the amount of the impairment.

22

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations as well as certain retained corporate costs. The segment data presented below is prepared in accordance with general accounting principles for segment reporting. The lines titled “reportable segment totals” in both net sales and segment operating profit, however, are non-GAAP measures when presented outside of the financial statement footnotes. Management has included reportable segment totals below to facilitate the discussion and analysis of financial condition and results of operations and believes this information allows the board of directors, management, investors and analysts to better understand the Company’s financial performance. The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit is not, however, intended as an alternative measure of operating results as determined in accordance with U.S. GAAP and is not necessarily comparable to similarly titled measures used by other companies.

In March 2020, the World Health Organization categorized the novel coronavirus (“COVID-19”) as a pandemic, and it continues to spread throughout the United States and other countries across the world. To limit the spread of COVID-19, governments have taken various actions, including the issuance of stay-at-home orders and social distancing guidelines. As a result, many businesses have adjusted, reduced or suspended operating activities, either due to requirements under government orders or as a result of a reduction in demand for many products from direct or ultimate customers. Fortunately, the manufacture of glass containers has been largely viewed as essential to the important food and beverage value chain in the countries in which the Company operates. However, the Company is still impacted by the broader supply chain issues and in some cases certain end use categories that it serves are not deemed essential. While most of the Company’s plants are operating as essential businesses, some plants have suspended or cut back on operating levels and shifts, and additional suspensions and cutbacks may occur as the impacts from COVID-19 and related responses continue to develop.

The following discussion describes the Company’s results of operations for the three months ended March 31, 2020. While the recent outbreak of COVID-19 primarily impacted the Company’s shipment and production levels in the latter part of the first quarter of 2020, the Company is actively monitoring the impact of the coronavirus outbreak, which will negatively impact its business, results of operations, cash flows and financial position for the second quarter of 2020 and likely beyond. The Company has summarized its current operating conditions and actions taken to mitigate the impact of COVID-19 below.

Financial information for the three months ended March 31, 2020 and 2019 regarding the Company’s reportable segments is as follows (dollars in millions):

	Three months ended
	March 31,
	2020		2019
Net Sales:
Americas	$	831	$	881
Europe		576		596
Asia Pacific		145		151
Reportable segment totals		1,552		1,628
Other		9		10
Net Sales	$	1,561	$	1,638

23

	Three months ended
	March 31,
	2020		2019
Segment operating profit:
Americas	$	103	$	113
Europe		61		79
Asia Pacific		5		8
Reportable segment totals		169		200
Items excluded from segment operating profit:
Retained corporate costs and other		(21)		(24)
Charge for deconsolidation of Paddock		(14)
Interest expense, net		(53)		(65)
Earnings before income taxes		81		111
Provision for income taxes		(26)		(27)
Net Earnings		55		84
Net earnings attributable to noncontrolling interests		(5)		(5)
Net earnings attributable to the Company	$	50	$	79

Note: All amounts excluded from reportable segment totals are discussed in the following applicable sections.

Executive Overview — Quarters ended March 31, 2020 and 2019

First Quarter 2020 Highlights

● Net sales in the first quarter of 2020 were down nearly 5% from the same quarter in 2019, primarily due to the unfavorable effects of changes in foreign currency exchange rates and lower volumes, partially offset by incremental sales from the Nueva Fanal acquisition in mid-2019 and higher prices.

● Segment operating profit for reportable segments was down nearly 16% in the first quarter of 2020 compared to the first quarter of 2019, primarily due to the unfavorable effects of changes in foreign currency, lower sales volumes and higher operating costs, driven by the nonoccurrence of energy credits and incentives recorded in 2019, partially offset by higher net selling prices and the positive impact from the Company’s turnaround initiatives.

● On January 6, 2020 (the “Petition Date”), Paddock voluntarily filed for relief under Chapter 11 of the Bankruptcy Code to equitably and finally resolve all of its current and future asbestos-related claims. O-I Glass and O-I Group were not included in the Chapter 11 filing. Following the Chapter 11 filing, Paddock became subject to review and oversight by the bankruptcy court. As a result, the Company no longer has exclusive control over Paddock’s activities during the bankruptcy proceedings. Therefore, Paddock was deconsolidated and its assets and liabilities were derecognized from the Company’s consolidated financial statements as of the Petition Date. Simultaneously, the Company recognized a $471 million liability related to its support agreement with Paddock. Taken together, these transactions resulted in a loss of approximately $14 million, which was recorded as a charge in the first quarter of 2020.

● In light of COVID-19, for the time being the Company has halted the strategic review of its Australia and New Zealand (“ANZ”) business and will continue to run the operations which are performing well. As market conditions stabilize, the Company will reevaluate alternatives for ANZ. The Company’s tactical divestiture program continues to advance, but at a slower than anticipated pace.

● While demand was stable for most of the first quarter, shipment and production levels did decline in several markets in late March reflecting the impact of COVID-19. The Company has temporarily curtailed some capacity to adapt to revised customer demand and comply with governmental public health decrees in certain countries. The Company has summarized its current operating conditions and its actions to mitigate the impact of COVID-19 below.

24

Net sales for the first quarter of 2020 were $77 million lower than the first quarter of the prior year primarily due to the unfavorable effect of changes in foreign currency exchange rates and lower sales volumes, partially offset by incremental sales from Nueva Fanal and higher prices.

Earnings before income taxes were $30 million lower in the first quarter of 2020 than the prior year quarter, primarily due to lower segment operating profit and a charge associated with the deconsolidation of Paddock following its Chapter 11 filing, partially offset by lower net interest expense. Segment operating profit for reportable segments for the first quarter of 2020 was $31 million lower than the first quarter of the prior year. The decrease was largely due to the unfavorable effect of changes in foreign currency exchange rates, lower sales volumes and higher operating costs primarily due to the nonoccurrence of energy credits and incentives recorded in 2019, partially offset by higher net selling prices and the positive impact from the Company’s turnaround initiatives.

Net interest expense for the first quarter of 2020 decreased $12 million compared to the first quarter of 2019, primarily due to the lower cost of debt as a result of refinancing activities in the prior year.

For the first quarter of 2020, the Company recorded net earnings attributable to the Company of $50 million, or $0.32 per share (diluted), compared to $79 million, or $0.51 per share (diluted), in the first quarter of 2019.

Results of Operations — First Quarter of 2020 compared with First Quarter of 2019

Net Sales

The Company’s net sales in the first quarter of 2020 were $1,561 million compared with $1,638 million for the first quarter of 2019, a decrease of $77 million, or nearly 5%. Unfavorable foreign currency exchange rates decreased sales by $75 million in the first quarter of 2020 compared to the prior year quarter as the U.S. dollar strengthened against all of the significant local currencies that impact the Company. Higher selling prices increased net sales by $19 million in the quarter. Total glass container shipments, in tonnes, were down approximately 0.8% in the first quarter of 2020 compared to the prior year quarter. Sales volumes in the first quarter reflected the net effect of an estimated 1.7% decline due to COVID-19, an estimated 1.1% decline in organic sales volumes and a 2% benefit from Nueva Fanal. Excluding the impact of the Nueva Fanal acquisition, total glass container shipments, in tonnes, were down approximately 3% in the first quarter of 2020 compared to the same period in the prior year and were primarily driven by lower alcoholic beverage shipments in the Americas and due to COVID-19. The net impact of lower organic sales more than offset the additional sales from the Nueva Fanal acquisition and resulted in a $20 million net reduction to net sales in the first quarter of 2020 compared to the same period in the prior year.

The change in net sales of reportable segments can be summarized as follows (dollars in millions):

Reportable segment net sales - 2019			$	1,628
Price	$	19
Sales volume and mix		(20)
Effects of changing foreign currency rates		(75)
Total effect on reportable segment net sales				(76)
Reportable segment net sales - 2020			$	1,552

Americas: Net sales in the Americas in the first quarter of 2020 were $831 million compared with $881 million for the first quarter of 2019, a decrease of $50 million, or nearly 6%. The unfavorable effects of foreign currency exchange rate changes decreased net sales $41 million in the first quarter of 2020 compared to 2019. Total glass container shipments in the region were down approximately 1% in the first quarter of 2020 compared to the prior year quarter. Excluding the impact of the Nueva Fanal acquisition in mid-2019 in the region, total glass container shipments were down approximately 5.4% in the first quarter of 2020 compared to the same period in the prior year, driven primarily by lower shipments to alcoholic beverage customers in the U.S. largely due to ongoing trends in beer shipments, and due to a decline in organic sales volumes linked to COVID-19. The net impact of lower organic sales more than offset the additional sales from the Nueva Fanal acquisition and resulted in a $15 million reduction to net sales in the first quarter of 2020 compared to the same period in 2019. Higher selling prices increased net sales by $6 million in the first quarter of 2020.

Europe: Net sales in Europe in the first quarter of 2020 were $576 million compared with $596 million for the first quarter of 2019, a decrease of $20 million, or 3%. Unfavorable foreign currency exchange rates impacted the region by

25

approximately $20 million in the first quarter of 2020 as the Euro weakened in relation to the U.S. dollar. Glass container shipments in the first quarter of 2020 were down approximately 2% compared to the first quarter of 2019, primarily driven by lower shipments to alcoholic beverage customers due to COVID-19, resulting in $12 million of lower net sales. Selling prices in Europe increased net sales by $12 million in the first quarter of 2020 compared to the same period in the prior year.

Asia Pacific: Net sales in Asia Pacific in the first quarter of 2020 were $145 million compared with $151 million for the first quarter of 2019, a decrease of $6 million, or 4%. The unfavorable effects of foreign currency exchange rate changes in the current year quarter decreased net sales by $14 million. Glass container shipments in the first quarter of 2020 were up nearly 7%, primarily driven by higher shipments to non-alcoholic beverage and food and other customers in Australia and China. This resulted in $7 million of higher net sales in the first quarter of 2020 compared to the prior year quarter. Higher selling prices increased net sales by $1 million in the first quarter of 2020.

Earnings before Income Taxes and Segment Operating Profit

Earnings before income taxes were $81 million in the first quarter of 2020 compared to $111 million in the first quarter of 2019, a decrease of $30 million, or 27%. This decrease was largely due to lower segment operating profit and a charge associated with the deconsolidation of Paddock following its Chapter 11 filing, partially offset by lower net interest expense.

Operating profit of the reportable segments includes an allocation of some corporate expenses based on a percentage of sales and direct billings based on the costs of specific services provided. Unallocated corporate expenses and certain other expenses not directly related to the reportable segments’ operations are included in Retained corporate costs and other. For further information, see Segment Information included in Note 1 to the Condensed Consolidated Financial Statements.

Segment operating profit of reportable segments in the first quarter of 2020 was $169 million compared to $200 million for the first quarter of 2019, a decrease of $31 million, or 16%. This decrease was largely due to the unfavorable effect of changes in foreign currency exchange rates, lower sales volumes and higher operating costs primarily due to the nonoccurrence of energy credits and incentives recorded in 2019, partially offset by higher net selling prices (net of cost inflation) and the positive impact from the Company’s turnaround initiatives.

The change in segment operating profit of reportable segments can be summarized as follows (dollars in millions):

Reportable segment operating profit - 2019			$	200
Net price (net of cost inflation)	$	3
Sales volume and mix		(12)
Operating costs		(9)
Effects of changing foreign currency rates		(13)
Total net effect on reportable segment operating profit				(31)
Reportable segment operating profit - 2020			$	169

Americas: Segment operating profit in the Americas in the first quarter of 2020 was $103 million compared with $113 million in the first quarter of 2019, a decrease of $10 million, or 9%. The impact of a change in mix and lower organic sales volumes discussed above more than offset the additional segment operating profit from the Nueva Fanal facility acquired in 2019 and resulted in a $10 million net reduction to segment operating profit in the first quarter of 2020 compared to the same period in the prior year. The effects of foreign currency exchange rates decreased segment operating profit by $6 million in the current year quarter. Improved operating performance in the region reduced operating costs and increased segment operating profit by $12 million in the first quarter and were driven by the Company’s turnaround initiatives. Cost inflation more than offset higher selling prices resulting in a net $6 million decrease to segment operating profit in the current year quarter.

Europe: Segment operating profit in Europe in the first quarter of 2020 was $61 million compared with $79 million in the first quarter of 2019, a decrease of $18 million, or 23%. The change in sales volume discussed above decreased segment operating profit in the current year quarter by $3 million. The effects of foreign currency exchange rates decreased segment operating profit by $4 million in the current year quarter. The region’s operating costs in the first

26

quarter of 2020 were approximately $9 million higher, which decreased segment operating profit, than the same period in the prior year due to more furnace repair activity. Also, the region’s operating costs were impacted by the nonoccurrence of approximately $15 million of energy credits and incentives from government entities that were recorded in the first quarter of 2019. Higher net selling prices (net of cost inflation) increased segment operating profit by $13 million in the current quarter compared to the prior year quarter.

Asia Pacific: Segment operating profit in Asia Pacific in the first quarter of 2020 was $5 million compared with $8 million in the first quarter of 2019, a decrease of $3 million, or 38%. The effects of foreign currency exchange rates decreased segment operating profit by $3 million in the current year quarter. The increase in sales volume discussed above benefitted segment operating profit by $1 million. Lower net selling prices (net of cost inflation) decreased segment operating profit by $4 million. The region also experienced approximately $3 million of lower operating costs, which improved segment operating income, in the first quarter of 2020 compared to the prior year quarter due to improved factory performance.

Interest Expense, Net

Net interest expense for the first quarter of 2020 was $53 million compared with $65 million for the first quarter of 2019 and decreased due to the lower cost of debt as a result of refinancing activities in the prior year.

Provision for Income Taxes

The Company’s effective tax rate from continuing operations for the three months ended March 31, 2020 was 32.1% compared with 24.3% for the three months ended March 31, 2019.  The effective tax rate for the first quarter of 2020 was higher than the first quarter of 2019 due primarily to a charge recorded as a result of the deconsolidation of Paddock, the geographic mix of earnings and recent regulatory changes in certain markets.

Net Earnings Attributable to the Company

For the first quarter of 2020, the Company recorded earnings attributable to the Company of $50 million, or $0.32 per share (diluted), compared to $79 million, or $0.51 per share (diluted), in the first quarter of 2019.
​

Forward Looking Operational and Financial Impacts from COVID-19

● Reflecting the challenges from the COVID-19 pandemic, month-to-date shipments through late April 2020 were down mid to high teens (in percentages) from the same period in the prior year, which includes the impact of temporary stoppage requirements in Mexico and the Andean countries. In April 2020, demand was down sharply in the first half of the month but the trend improved over the second half of the month. Excluding the markets impacted by temporary stoppage requirements like Mexico and the Andean countries, global demand was down less than 10 percent during the last two weeks of April. The Company does not believe these rates reflect true demand patterns given the current level of market and supply chain disruptions as well as inventory corrections. The Company expects that shipment levels will normalize as markets reopen.

● Total committed liquidity, including cash-on-hand as well as undrawn availability on committed lines of credit, remained strong through April 2020. The Company intends to maintain its liquidity at or above $1.25 billion at each quarter end of 2020.

● In response to the unprecedented nature of the pandemic, the Company is taking a number of preemptive measures to reduce costs and preserve the Company’s financial flexibility. Cash generation is the top financial priority and the Company is taking actions to quickly align supply with evolving demand trends as well as closely managing working capital levels. 2020 capital expenditures should approximate $300 million or lower. In addition to an expanded SG&A reduction initiative, the Company is initiating a program to temporarily reduce salaries for certain executive officers, including the CEO, and Board fees payable to non-employee members of the Board and director nominees by up to 25 percent during 2020. The amount of these reductions will generally be repaid in or about January 2021, and no later than March 15, 2021, subject to certain conditions, including the attainment of financial and/or other Company performance goals. The Company will also defer salaries for certain other salaried employees up to 15 percent during 2020, with deferred amounts generally being repaid with interest in or about January 2021, and no later than March 15, 2021. Salary deferrals, reductions and repayment terms will

27

be subject to compliance with applicable local law. Furthermore, the Company is suspending its dividend and is pausing the share repurchase program. The status of these efforts will be reviewed regularly, but the Company anticipates these measures will continue through 2020.    

● Despite headwinds from the pandemic, the Company continues to focus on long-term value creation including its turnaround initiatives, footprint optimization efforts, MAGMA deployment and resolution of legacy asbestos liabilities. In light of COVID-19, for the time being the Company has halted the strategic review of its Australia and New Zealand (“ANZ”) business and will continue to run the operations which are performing well. As market conditions stabilize, the Company will reevaluate alternatives for ANZ. The Company’s tactical divestiture program continues to advance, but at a slower than anticipated pace.

● The Company is actively monitoring the impact of the COVID-19 outbreak, which will negatively impact its business and results of operations for the second quarter of 2020 and likely beyond.  The extent to which the Company’s operations will be impacted by the outbreak will depend largely on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the outbreak and actions by government authorities to contain the outbreak or treat its impact, among other things.

Items excluded from Reportable Segment Totals

Retained Corporate Costs and Other

Retained corporate costs and other for the first quarter of 2020 were $21 million compared with $24 million recorded in the first quarter of 2019. These costs were lower in 2020 primarily due to efforts to reduce costs and gains realized on certain hedges, partially offset by the nonoccurrence of equity earnings from a soda ash joint venture that was sold by the Company in the fourth quarter of 2019.

Charge for Paddock Deconsolidation

Following its Chapter 11 filing, the activities of Paddock are now subject to review and oversight by the bankruptcy court. As a result, the Company no longer has exclusive control over Paddock’s activities during the bankruptcy proceedings. Therefore, Paddock was deconsolidated as of the Petition Date, and its assets and liabilities, which primarily included $47 million of cash, the legacy asbestos-related liabilities, as well as certain other assets and liabilities, were derecognized from the Company’s consolidated financial statements. Simultaneously, the Company recognized a liability related to the support agreement of $471 million, based on the accrual required under applicable accounting standards. Taken together, these transactions resulted in a loss of approximately $14 million, which was recorded as a charge in the first quarter of 2020.

See Note 10 to the Condensed Consolidated Financial Statements for further information.

Discontinued Operations

On December 6, 2018, an ad hoc committee for the World Bank’s International Centre for Settlement of Investment Disputes (“ICSID”) rejected the request by the Bolivarian Republic of Venezuela (“Venezuela”) to annul the award issued by an ICSID tribunal in favor of OI European Group B.V. (“OIEG”) related to the 2010 expropriation of OIEG’s majority interest in two plants in Venezuela (the “Award”). The annulment proceeding with respect to the Award is now concluded.

On July 31, 2017, OIEG sold its right, title and interest in amounts due under the Award to an Ireland-domiciled investment fund. Under the terms of the sale, OIEG received a payment, in cash, at closing equal to $115 million (the “Cash Payment”). OIEG may also receive additional payments in the future (“Deferred Amounts”) calculated based on the total compensation that is received from Venezuela as a result of collection efforts or as settlement of the Award with Venezuela. OIEG’s right to receive any Deferred Amounts is subject to the limitations described below.

OIEG’s interest in any amounts received in the future from Venezuela in respect of the Award is limited to a percentage of such recovery after taking into account reimbursement of the Cash Payment to the purchaser and reimbursement of legal fees and expenses incurred by the Company and the purchaser. OIEG’s percentage of such recovery will also be reduced over time. Because the Award has yet to be satisfied and the ability to successfully enforce the Award in countries that are party to the ICSID Convention is subject to significant challenges, the Company is unable to reasonably predict the amount of recoveries from the Award, if any, to which the Company may be entitled

28

in the future. Any future amounts that the Company may receive from the Award are highly speculative and the timing of any such future payments, if any, is highly uncertain. As such, there can be no assurance that the Company will receive any future payments under the Award beyond the Cash Payment.

A separate arbitration involving two other subsidiaries of the Company -- Fabrica de Vidrios Los Andes, C.A.(“Favianca”), and Owens-Illinois de Venezuela, C.A. (“OIDV”) -- was initiated in 2012 to obtain compensation primarily for third-party minority shareholders’ lost interests in the two expropriated plants. However, on November 13, 2017, ICSID issued an award that dismissed this arbitration on jurisdiction grounds.  In March 2018, OIDV and Favianca submitted to ICSID an application to annul the November 13, 2017 award; on November 22, 2019, OIDV and Favianca’s request to annul the award was rejected by an ICSID ad hoc committee.  The two subsidiaries are evaluating potential next steps.

For each of the three-month periods ended March 31, 2020 and March 31, 2019, the Company did not incur any significant losses from discontinued operations.

Capital Resources and Liquidity

On June 25, 2019, certain of the Company’s subsidiaries entered into a new Senior Secured Credit Facility Agreement (as amended by that certain Amendment No. 1 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 13, 2019, and as further amended by that certain Amendment No. 2 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 19, 2019, the “Agreement”), which amended and restated the previous credit agreement (the “Previous Agreement”). The proceeds from the Agreement were used to repay all outstanding amounts under the Previous Agreement.

The Agreement provides for up to $3.0 billion of borrowings pursuant to term loans and revolving credit facilities. The term loans mature, and the revolving credit facilities terminate, in June 2024. At March 31, 2020, the Agreement includes a $300 million revolving credit facility, a $1.2 billion multicurrency revolving credit facility, and a $1.5 billion term loan A facility ($1,477 million net of debt issuance costs). At March 31, 2020, the Company had unused credit of $673 million available under the Agreement. The weighted average interest rate on borrowings outstanding under the Agreement at March 31, 2020 was 2.28%.

The Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.

The Agreement also contains one financial maintenance covenant, a Total Leverage Ratio (the “Leverage Ratio”), that requires the Company not to exceed a ratio of 5.0x calculated by dividing consolidated total debt, less cash and cash equivalents, by Consolidated EBITDA, with such Leverage Ratio decreasing to (a) 4.75x for the quarter ending June 30, 2021 and (b) 4.50x for the quarter ending December 31, 2021 and thereafter, as defined and described in the Agreement. The maximum Leverage Ratio is subject to an increase of 0.5x for (i) any fiscal quarter during which certain qualifying acquisitions (as specified in the Agreement) are consummated and (ii) the following three fiscal quarters, provided that the Leverage Ratio shall not exceed 5.0x. The Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Leverage Ratio to exceed the specified maximum.

Failure to comply with these covenants and other customary restrictions could result in an event of default under the Agreement. In such an event, the Company could not request borrowings under the revolving facilities, and all amounts outstanding under the Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Agreement. If an event of default occurs under the Agreement and the lenders cause all of the outstanding debt obligations under the Agreement to become due and payable, this would result in a default under the indenture governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of March 31, 2020, the Company was in compliance with

29

all covenants and restrictions in the Agreement.  In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Agreement will not be adversely affected by the covenants and restrictions.

The Leverage Ratio also determines pricing under the Agreement. The interest rate on borrowings under the Agreement is, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Agreement, plus an applicable margin. The applicable margin is linked to the Leverage Ratio. The margins range from 1.00% to 1.50% for Eurocurrency Loans and from 0.00% to 0.50% for Base Rate Loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Leverage Ratio.

Obligations under the Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Agreement are guaranteed by certain foreign subsidiaries of the Company.

In July 2019, the Company redeemed €250 million aggregate principal amount of its outstanding 6.75% senior notes due 2020. The redemption was funded with cash on hand and revolver borrowings.

In November 2019, the Company issued €500 million aggregate principal amount of new senior notes. The new senior notes bear interest at a rate of 2.875% per annum and mature on February 15, 2025. The new senior notes were issued via a private placement and are guaranteed by certain of the Company’s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately €492 million and were used to redeem the remaining €250 million aggregate principal amount of the Company’s outstanding 6.75% senior notes due 2020 and approximately €212 million aggregate principal amount of the Company’s outstanding 4.875% senior notes due 2021.

In December 2019, subsidiaries of the Company completed consent solicitations to amend and waive certain provisions of the indentures governing certain of their senior notes. On December 11, 2019, those subsidiaries entered into supplemental indentures reflecting the amendments and waivers, which were obtained to facilitate the implementation of the Corporate Modernization.

In order to maintain a capital structure containing appropriate amounts of fixed and floating-rate debt, the Company has entered into a series of interest rate swap agreements. These interest rate swap agreements were accounted for as either fair value hedges or cash flow hedges (see Note 5 for more information).

The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.

Cash Flows

Operating activities: Cash utilized by continuing operating activities was $315 million for the three months ended March 31, 2020, compared to $595 million utilized for the three months ended March 31, 2019. The decrease in cash utilized by operating activities in the first quarter of 2020 was primarily due to the staying of all asbestos-related payments as a result of Paddock’s Chapter 11 filing in early January 2020 and lower working capital levels than in the same period in 2019, partially offset by lower net earnings. See Note 10 to the Condensed Consolidated Financial Statements for additional information on Paddock.

Working capital was a use of cash of $461 million in the first three months of 2020 compared to a use of cash of $697 million in the same period in 2019. The primary reasons for the lower use of working capital in the first quarter of 2020 compared to the same period in the prior year was due to accounts receivable and accounts payable activity. As of March 31, 2020 and 2019, the Company reduced its level of accounts receivable factoring compared to the most recent respective year-end periods and this led to a use of working capital in both the first quarter of 2020 and 2019. The reduction in accounts receivable factoring compared to the most recent year end period was approximately $187 million

30

less in the first quarter of 2020 than in 2019 and this contributed to a lower use of working capital in the 2020 period. Also, due to the timing of payments, the Company’s accounts payable balances did not decline as significantly in the first quarter of 2020 as they did in the first quarter of 2019, and this resulted in a lower use of cash in the first quarter of 2020.

Investing activities: Cash utilized in investing activities was $165 million for the three months ended March 31, 2020, compared to $135 million utilized for the three months ended March 31, 2019. Capital spending for property, plant and equipment was $120 million during the first three months of 2020 compared to $121 million in the same period in 2019. Contributions and advances to joint ventures were $0 and $15 million in the first three months of 2020 and 2019, respectively. No significant contributions are planned to the Company’s joint ventures in 2020. Following the Chapter 11 filing in January 2020, the activities of Paddock are now subject to review and oversight by the bankruptcy court. As a result, the Company no longer has exclusive control over Paddock’s activities during the bankruptcy proceedings. Therefore, Paddock was deconsolidated and its assets and liabilities were derecognized from the Company’s financial statements, which resulted in an investing outflow of $47 million in the Company’s first quarter 2020 condensed consolidated cash flows. See Note 10 to the Condensed Consolidated Financial Statements for more information.

In response to the COVID-19 pandemic, the Company is taking a number of measures to reduce costs and preserve its financial flexibility. The Company estimates that its full year 2020 capital expenditures should be approximately $300 million or lower.

Financing activities:  Cash provided by financing activities was $849 million for the three months ended March 31, 2020, compared to $540 million for the three months ended March 31, 2019. The increase in cash provided by financing activities was primarily due to higher net borrowings in the first quarter of 2020. In March 2020, the company borrowed approximately $600 million on its $1.5 billion revolving credit facility to bolster cash-on-hand as a proactive measure to ensure financial flexibility.    

The Company paid $8 million in dividends in each of the first quarters of 2020 and 2019. Through the first three months ended March 31, 2020 and 2019, the Company had repurchased $0 and approximately $38 million of the Company’s stock. In response to the COVID-19 pandemic, the Company has suspended its dividend and has paused share repurchases at this time. The status of these efforts will be reviewed regularly, but the Company anticipates these measures will continue through 2020.

The Company anticipates that cash flows from its opera­tions and from utiliza­tion of credit available under the Agreement will be sufficient to fund its operating and seasonal working capital needs, debt service and other obligations on a short-term (twelve months) and long-term basis. However, as the Company cannot predict the duration or scope of the COVID-19 pandemic and its impact on its customers and suppliers, the negative financial impact to the Company’s results cannot be reasonably estimated, but could be material. The Company is actively managing the business to maintain cash flow and it has significant liquidity. The Company believes that these factors will allow it to meet its anticipated funding requirements. The Company anticipates that cash flows in 2020 will benefit from the operation of the automatic stay in Paddock’s Chapter 11 filing, which stays ongoing litigation and submission of claims and defers payment in connection with asbestos-related liabilities.

Critical Accounting Estimates

The Company’s analysis and discussion of its financial condition and results of operations are based upon its consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. The Company evaluates these estimates and assumptions on an ongoing basis. Estimates and assumptions are based on historical and other factors believed to be reasonable under the circumstances at the time the financial statements are issued. The results of these estimates may form the basis of the carrying value of certain assets and liabilities and may not be readily apparent from other sources. Actual results, under conditions and circumstances different from those assumed, may differ from estimates.

The impact of, and any associated risks related to, estimates and assumptions are discussed within Management’s Discussion and Analysis of Financial Condition and Results of Operations, as well as in the Notes to the Condensed Consolidated Financial Statements, if applicable, where estimates and assumptions affect the Company’s reported and expected financial results.

31

There have been no other material changes in critical accounting estimates at March 31, 2020 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Forward-Looking Statements

This document contains “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 27A of the Securities Act of 1933. Forward-looking statements reflect the Company's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward-looking statements.

It is possible that the Company’s future financial performance may differ from expectations due to a variety of factors including, but not limited to the following: (1) the Company’s ability to obtain the benefits it anticipates from the Corporate Modernization, (2) risks inherent in, and potentially adverse developments related to, the Chapter 11 bankruptcy proceeding involving Paddock, that could adversely affect the Company and the Company’s liquidity or results of operations, including the impact of deconsolidating Paddock from the Company’s financials, risks from asbestos-related claimant representatives asserting claims against the Company and potential for litigation and payment demands against the Company by such representatives and other third parties, (3) the amount that will be necessary to fully and finally resolve all of Paddock’s asbestos-related claims and the Company’s obligations to make payments to resolve such claims under the terms of its support agreement with Paddock, (4) the Company’s ability to manage its cost structure, including its success in implementing restructuring or other plans aimed at improving the Company’s operating efficiency and working capital management, achieving cost savings, and remaining well-positioned to address the Company’s legacy liabilities, (5) the Company’s ability to acquire or divest businesses, acquire and expand plants, integrate operations of acquired businesses and achieve expected benefits from acquisitions, divestitures or expansions, (6) the Company’s ability to achieve its strategic plan, (7) foreign currency fluctuations relative to the U.S. dollar, (8) changes in capital availability or cost, including interest rate fluctuations and the ability of the Company to refinance debt on favorable terms, (9) the general political, economic and competitive conditions in markets and countries where the Company has operations, including uncertainties related to Brexit, economic and social conditions, disruptions in the supply chain, competitive pricing pressures, inflation or deflation, changes in tax rates and laws, natural disasters and weather, (10) the impact of COVID-19 and the various governmental, industry and consumer actions related thereto, (11) the Company’s ability to generate sufficient future cash flows to ensure the Company’s goodwill is not impaired, (12) consumer preferences for alternative forms of packaging, (13) cost and availability of raw materials, labor, energy and transportation, (14) consolidation among competitors and customers, (15) unanticipated expenditures with respect to data privacy, environmental, safety and health laws, (16) unanticipated operational disruptions, including higher capital spending, (17) the Company’s ability to further develop its sales, marketing and product development capabilities, (18) the failure of the Company’s joint venture partners to meet their obligations or commit additional capital to the joint venture, (19) the ability of the Company and the third parties on which it relies for information technology system support to prevent and detect security breaches related to cybersecurity and data privacy, (20) changes in U.S. trade policies, and the other risk factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and any subsequently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q or the Company’s other filings with the Securities and Exchange Commission.

It is not possible to foresee or identify all such factors. Any forward-looking statements in this document are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate in the circumstances. Forward-looking statements are not a guarantee of future performance and actual results or developments may differ materially from expectations. While the Company continually reviews trends and uncertainties affecting the Company's results of operations and financial condition, the Company does not assume any obligation to update or supplement any particular forward-looking statements contained in this document.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes in market risk at March 31, 2020 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

32

Item 4. Controls and Procedures.

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Also, the Company has investments in certain unconsolidated entities. As the Company does not control or manage these entities, its disclosure controls and procedures with respect to such entities are necessarily substantially more limited than those maintained with respect to its consolidated subsidiaries.

As required by Rule 13a-15(b) of the Exchange Act, the Company carried out an evaluation, under the supervision and with the participation of management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2020.

As required by Rule 13a-15(d) of the Exchange Act, the Company carried out an evaluation, under the supervision and with the participation of management, including its Chief Executive Officer and Chief Financial Officer, of any change in the Company’s internal controls over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal controls over financial reporting. There have been no changes in the Company’s internal controls over financial reporting during the fiscal quarter ended March 31, 2020 that have materially affected, or are reasonably likely to material affect, the Company’s internal controls over financial reporting.

33

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

For further information on legal proceedings, see Note 10 to the Condensed Consolidated Financial Statements, “Contingencies,” that is included in Part I of this Quarterly Report and incorporated herein by reference.

Item 1A. Risk Factors.

Other than below, there have been no material changes in risk factors at March 31, 2020 from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

The novel coronavirus (COVID-19) has resulted, and may likely continue to result in material adverse effects on the Company’s business, financial position, liquidity, results of operations and cash flows.

The COVID-19 pandemic, and the various governmental, industry and consumer actions related thereto, have had, and may likely continue to have, negative impacts on the Company’s business. These impacts include, without limitation, significant volatility or decreases in the demand for the Company’s products, changes in customer and consumer behavior and preferences, disruptions in or closures of the Company’s manufacturing operations or those of its customers and suppliers, disruptions within the Company’s supply chain, limitations on the Company’s employees’ ability to work and travel, potential financial difficulties of customers and suppliers, significant changes in economic or political conditions, and related financial and commodity volatility, including volatility in raw material and other input costs.

In addition, future changes in the Company’s cost of capital, expected cash flows, or other factors as a result of the above may cause the Company’s long-lived assets including goodwill to be impaired, resulting in a non-cash charge against results of operations to write down long-lived assets including goodwill for the amount of the impairment.

To the extent the COVID-19 pandemic adversely affects the Company’s business and financial results, it may also have the effect of heightening many of the other risks described in Item 1A, “Risk Factors” of the Company’s annual report on Form 10-K for the year ended December 31, 2019 and any subsequently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q or the Company’s other filings with the Securities and Exchange Commission., such as those relating to the Company’s ability to service its indebtedness; the restrictions placed on the Company under its existing indebtedness; fluctuations in foreign exchange rates; international operations; changes in consumer demand; the global economic environment; operational disruptions; the availability and cost of raw materials; reliance on key management and personnel; joint ventures; cybersecurity and data privacy; and goodwill; among others.

Despite the Company’s efforts to manage the impacts, the degree to which COVID-19 and related actions will ultimately impact the Company’s business, financial position, liquidity, results of operations and cash flows will depend on factors that are beyond its control, highly uncertain and cannot be predicted, including the duration, spread and severity of the outbreak, the various legislation and other responses taken in the United States and other countries to contain COVID-19 and mitigate its public health effects, the impact on the U.S. and global economies and demand for the Company’s products, and how quickly and to what extent normal economic and operating conditions resume.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The Company did not purchase any shares of its common stock for the three months ended March 31, 2020. The Company has $380 million remaining for repurchases pursuant to authorization by its Board of Directors in January 2018 to purchase up to $400 million of the Company's common stock along with an authorization by its Board of Directors in November 2018 to purchase an additional $313 million of the Company’s common stock.

34

Item 6. Exhibits.

Exhibit 31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1*	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350.
Exhibit 32.2*	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.
Exhibit 101	Financial statements from the Quarterly Report on Form 10-Q of O-I Glass, Inc. for the quarter ended March 31, 2020, were formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Results of Operations, (ii) the Condensed Consolidated Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Cash Flows and (v) the Notes to Condensed Consolidated Financial Statements.
Exhibit 104	Cover Page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101)

* This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		O-I GLASS, INC.
Date	April 29, 2020	By	/s/ John A. Haudrich
			John A. Haudrich
			Senior Vice President and Chief Financial Officer

36

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Andres A. Lopez, certify that:

1. I have reviewed this quarterly report on Form 10-Q of O-I Glass, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 29, 2020	/s/ Andres A. Lopez
		Andres A. Lopez
		President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, John A. Haudrich, certify that:

1. I have reviewed this quarterly report on Form 10-Q of O-I Glass, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 29, 2020	/s/ John A. Haudrich
		John A. Haudrich
		Senior Vice President and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of O-I Glass, Inc. (the “Company”) hereby certifies that to such officer’s knowledge:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March  31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:April 29,  2020	/s/ Andres A. Lopez
	Andres A. Lopez
	President and Chief Executive Officer

EX-32.2

EXHIBIT 32.2

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of O-I Glass, Inc. (the “Company”) hereby certifies that to such officer’s knowledge:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 29,  2020	/s/ John A. Haudrich
	John A. Haudrich
	Senior Vice President and Chief Financial Officer

XML

Other Expense, net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Other Expense, net
Charge for deconsolidation of Paddock	$ 14
Foreign currency exchange loss		$ 3
Intangible amortization expense	10	10
Royalty income	(4)	(3)
Other expense (income), net	(3)
Other expense, net	$ 17	$ 10

XML

Business Combinations (Details) - Nueva Fbrica Nacional de Vidrio, S. de R.L. de C.V. ("Nueva Fanal") $ in Millions	Jun. 28, 2019 USD ($) Plant T
Measurement period adjustments
Cash paid for acquisition	$ 188
Number of furnaces in the Nueva Fanal facility | Plant	3
Tonnage of glass containers produced by Nueva Fbrica Nacional de Vidrio, S. de R.L. de C.V. ("Nueva Fanal") | T	240,000
Pro forma financial information	$ 0

XML

CONSOLIDATED RESULTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CONSOLIDATED RESULTS OF OPERATIONS
Net sales	$ 1,561	$ 1,638
Revenue, Product and Service [Extensible List]	Net sales	Net sales
Cost of goods sold	$ (1,293)	$ (1,340)
Gross profit	268	298
Selling and administrative expense	(116)	(115)
Research, development and engineering expense	(16)	(16)
Interest expense, net	(53)	(65)
Equity earnings	15	19
Other expense, net	(17)	(10)
Earnings before income taxes	81	111
Provision for income taxes	(26)	(27)
Net earnings	55	84
Net earnings attributable to noncontrolling interests	(5)	(5)
Net earnings attributable to the Company	$ 50	$ 79
Basic earnings per share:
Net earnings attributable to the Company (in dollars per share)	$ 0.32	$ 0.51
Weighted average shares outstanding (thousands) (in shares)	156,081	154,361
Diluted earnings per share:
Net earnings attributable to the Company (in dollars per share)	$ 0.32	$ 0.51
Weighted average diluted shares outstanding (thousands) (in shares)	157,684	156,635

XML

CONDENSED CONSOLIDATED CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net earnings	$ 55	$ 84
Non-cash charges
Depreciation and amortization	126	126
Pension expense	9	8
Cash payments
Pension contributions	(13)	(11)
Asbestos-related payments		(71)
Cash paid for restructuring activities	(8)	(15)
Change in components of working capital	(461)	(697)
Other, net (a)	(23)	(19)
Cash utilized in operating activities	(315)	(595)
Cash flows from investing activities:
Cash payments for property, plant and equipment	(120)	(121)
Contributions and advances to joint ventures		(15)
Net cash proceeds on disposal of assets		1
Deconsolidation of Paddock	(47)
Other, net	2
Cash utilized in investing activities	(165)	(135)
Cash flows from financing activities:
Changes in borrowings, net	859	589
Issuance of common stock and other	(2)	(3)
Treasury shares repurchased		(38)
Dividend paid	(8)	(8)
Cash provided by financing activities	849	540
Effect of exchange rate fluctuations on cash	(29)	4
Increase (Decrease) in cash	340	(186)
Cash at beginning of period	551	512
Cash at end of period	$ 891	$ 326

XML

Accumulated Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2020

Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss)

12. Accumulated Other Comprehensive Loss

The activity in accumulated other comprehensive loss for the three months ended March 31, 2020 and 2019 is as follows:

									Total
									Accumulated
	Net Effect of		Change in Certain						Other
	Exchange Rate		Derivative			Employee			Comprehensive
	Fluctuations		Instruments			Benefit Plans			Loss
Balance on January 1, 2020	$	(813)	$	(14)		$	(1,016)		$	(1,843)
Change before reclassifications		(564)		(2)			(2)			(568)
Amounts reclassified from accumulated other comprehensive income (loss)				11	(a)		17	(b)		28
Translation effect				(1)			16			15
Tax effect				(2)						(2)
Other comprehensive income (loss) attributable to the Company		(564)		6			31			(527)
Balance on March 31, 2020	$	(1,377)	$	(8)		$	(985)		$	(2,370)

									Total
									Accumulated
	Net Effect of		Change in Certain						Other
	Exchange Rate		Derivative			Employee			Comprehensive
	Fluctuations		Instruments			Benefit Plans			Loss
Balance on January 1, 2019	$	(889)	$	(18)		$	(1,061)		$	(1,968)
Change before reclassifications		46		(2)			(2)			42
Amounts reclassified from accumulated other comprehensive income (loss)				3	(a)		13	(b)		16
Translation effect				2			(5)			(3)
Tax effect				2						2
Other comprehensive income (loss) attributable to the Company		46		5			6			57
Balance on March 31, 2019	$	(843)	$	(13)		$	(1,055)		$	(1,911)

(a) Amount is included in Cost of goods sold and Other expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information).

(b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net postretirement benefit cost.

XML

Inventories

3 Months Ended

Mar. 31, 2020

Inventories

Inventories

4. Inventories

Major classes of inventory at March 31, 2020, December 31, 2019 and March 31, 2019 are as follows:

	March 31,		December 31,		March 31,
	2020		2019		2019
Finished goods	$	884	$	872	$	868
Raw materials		121		128		126
Operating supplies		42		45		44
	$	1,047	$	1,045	$	1,038

XML

Income Taxes

3 Months Ended

Mar. 31, 2020

Income Taxes

Income Taxes

8. Income Taxes

The Company calculates its interim tax provision using the estimated annual effective tax rate (“EAETR”) methodology in accordance with ASC 740-270. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income or loss in each tax jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the quarter they occur in accordance with GAAP. Depending on various factors such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. The Company’s annual effective tax rate may be affected by the mix of earnings in the U.S. and foreign jurisdictions and such factors as changes in tax laws, tax rates or regulations, changes in business, changing interpretation of existing tax laws or regulations, the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions. The annual effective tax rate differs from the statutory U.S. Federal tax rate of 21% primarily because of varying non-U.S. tax rates.

The Company is currently under examination in various tax jurisdictions in which it operates, including Bolivia, Brazil, Canada, Colombia, France, Germany, Indonesia and Peru. The years under examination range from 2004 through 2018. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies such as appeals and litigation, if necessary. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s results of operations, financial position or cash flows.

On March 27, 2020, the President of the United States signed the Coronavirus Aid, Relief, and Economic Security (CARES) Act into law. The CARES Act is an emergency economic stimulus package in response to the coronavirus outbreak that provides numerous tax provisions and other stimulus measures. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Some international jurisdictions in which the Company operates have also enacted legislation to provide economic stimulus in response to the coronavirus outbreak. The Company anticipates it may benefit from the ability to defer U.S. social security payroll tax that would otherwise be required in 2020, the acceleration of alternative minimum tax credit refunds, and potentially other provisions within the CARES Act. In addition, the Company may benefit from the deferral of certain non-U.S. tax payments to a future period. The Company expects the CARES Act and international legislation will not have a material impact on the Company’s condensed consolidated financial statements.

XML

Business Combinations (Tables)

3 Months Ended

Mar. 31, 2020

Business Combinations

Schedule of preliminary estimates of fair value of the assets and liabilities

		June 28, 2019		Measurement Period Adjustments		March 31, 2020
Accounts receivable	$	42	$	—	$	42
Inventory		17				17
Goodwill				18		18
Intangibles		35		(32)		3
Net property, plant and equipment		129		32		161
Total assets acquired		223		18		241
Accounts payable		25		1		26
Accrued liabilities		3		(1)		2
Deferred tax liabilities				25		25
Net assets acquired	$	195	$	(7)	$	188

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2020

Accumulated Other Comprehensive Income (Loss)

Component of accumulated other comprehensive loss

									Total
									Accumulated
	Net Effect of		Change in Certain						Other
	Exchange Rate		Derivative			Employee			Comprehensive
	Fluctuations		Instruments			Benefit Plans			Loss
Balance on January 1, 2020	$	(813)	$	(14)		$	(1,016)		$	(1,843)
Change before reclassifications		(564)		(2)			(2)			(568)
Amounts reclassified from accumulated other comprehensive income (loss)				11	(a)		17	(b)		28
Translation effect				(1)			16			15
Tax effect				(2)						(2)
Other comprehensive income (loss) attributable to the Company		(564)		6			31			(527)
Balance on March 31, 2020	$	(1,377)	$	(8)		$	(985)		$	(2,370)

									Total
									Accumulated
	Net Effect of		Change in Certain						Other
	Exchange Rate		Derivative			Employee			Comprehensive
	Fluctuations		Instruments			Benefit Plans			Loss
Balance on January 1, 2019	$	(889)	$	(18)		$	(1,061)		$	(1,968)
Change before reclassifications		46		(2)			(2)			42
Amounts reclassified from accumulated other comprehensive income (loss)				3	(a)		13	(b)		16
Translation effect				2			(5)			(3)
Tax effect				2						2
Other comprehensive income (loss) attributable to the Company		46		5			6			57
Balance on March 31, 2019	$	(843)	$	(13)		$	(1,055)		$	(1,911)

(a) Amount is included in Cost of goods sold and Other expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information).

(b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net postretirement benefit cost.

XML

New Accounting Pronouncement

3 Months Ended

Mar. 31, 2020

New Accounting Pronouncement

New Accounting Pronouncement

16. New Accounting Pronouncement

Credit Losses - Effective January 1, 2020, the Company adopted ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables. The amendment requires entities to consider a broader range of information to estimate expected credit losses, which may result in earlier recognition of losses. The adoption of ASU No. 2016-13 had no cumulative effect adjustment as of January 1, 2020 and no material impact on the Company’s consolidated balance sheet, consolidated results of operations or consolidated cash flows. See Note 3 for additional information.
​

Disclosure Requirements for Fair Value Measurement - In August 2018, the FASB issued ASU No. 2018-13, “Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement” which modifies the fair value disclosure requirements. Application of the standard is required for annual periods beginning after December 15, 2019. The Company adopted this standard in the first quarter of 2020. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

Disclosure Requirements for Defined Benefit Plans - In August 2018, the FASB issued ASU No. 2018-14, “Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans” which modifies the defined benefit plan disclosure requirements. Application of the standard is required for annual periods beginning after December 15, 2020. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2020

Revenue

Schedule of disaggregation of revenue by customer end use

	Three months ended March 31, 2020
	Americas		Europe		Asia Pacific		Total
Alcoholic beverages (beer, wine, spirits)	$	508	$	411	$	101	$	1,020
Food and other		189		105		24		318
Non-alcoholic beverages		134		60		20		214
Reportable segment totals	$	831	$	576	$	145	$	1,552
Other								9
Net sales							$	1,561
	Three months ended March 31, 2019
	Americas		Europe		Asia Pacific		Total
Alcoholic beverages (beer, wine, spirits)	$	564	$	432	$	109	$	1,105
Food and other		180		103		25		308
Non-alcoholic beverages		137		61		17		215
Reportable segment totals	$	881	$	596	$	151	$	1,628
Other								10
Net sales							$	1,638

XML

Pension Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
U.S.
Components of net periodic pension cost
Service cost	$ 3	$ 3
Interest cost	12	15
Expected asset return	(21)	(22)
Amortization:
Amortization of actuarial loss	14	10
Net periodic pension cost	8	6
Non-U.S.
Components of net periodic pension cost
Service cost	3	3
Interest cost	7	8
Expected asset return	(12)	(12)
Amortization:
Amortization of actuarial loss	3	3
Net periodic pension cost	$ 1	$ 2

XML

Derivative Instruments - Derivatives and Hedges (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Commodity forward contracts | Cash Flow Hedges
Derivatives and Hedges
Unrecognized (loss) gain included in Accumulated OCI	$ (2)	$ 1	$ 3
Cross-currency swap | Cash Flow Hedges
Derivatives and Hedges
Unrecognized (loss) gain included in Accumulated OCI	(4)	(1)	(11)
Interest rate swaps | Cash Flow Hedges | Maximum
Derivatives and Hedges
Unrecognized (loss) gain included in Accumulated OCI	(1)	(1)	(1)
Interest rate swaps | Net investment hedges
Derivatives and Hedges
Unrecognized (loss) gain included in Accumulated OCI	$ 10	$ 8	$ 7

XML

Business Combinations

3 Months Ended

Mar. 31, 2020

Business Combinations

Business Combinations

17. Business Combinations

On June 28, 2019, the Company completed the acquisition of Nueva Fábrica Nacional de Vidrio, S. de R.L. de C.V. (“Nueva Fanal”) from Grupo Modelo, an affiliate of Anheuser-Busch InBev SA/NV for a total purchase price of approximately $188 million. The Company financed this acquisition with debt. The Nueva Fanal facility is located near Mexico City, Mexico. Currently, this plant has three furnaces to produce and supply approximately 240,000 tons of glass containers annually for Grupo Modelo brands, such as Corona, for local and global export markets. This acquisition increases the Company’s presence in the Mexican glass packaging market.

Nueva Fanal’s operating results are included in the Company’s Consolidated Financial Statements from the acquisition date as part of the Americas segment. The acquisition qualifies as a business combination and will be accounted for using the acquisition method of accounting.

The total purchase price will be allocated to the tangible and identifiable intangible assets and liabilities based upon their respective fair values. The aggregate purchase price was preliminarily allocated to the Company’s balance sheet as of March 31, 2020, and has not yet been finalized because the Company has not yet completed the valuation of the acquired property, plant and equipment and the related depreciation periods. The Company expects that the purchase price allocation process will be completed no later than the second quarter of 2020. The following table summarizes the preliminary estimates of fair value of the assets acquired and liabilities assumed on June 28, 2019 and subsequent adjustments identified through the ongoing purchase price allocation process and recorded through the measurement period:

		June 28, 2019		Measurement Period Adjustments		March 31, 2020
Accounts receivable	$	42	$	—	$	42
Inventory		17				17
Goodwill				18		18
Intangibles		35		(32)		3
Net property, plant and equipment		129		32		161
Total assets acquired		223		18		241
Accounts payable		25		1		26
Accrued liabilities		3		(1)		2
Deferred tax liabilities				25		25
Net assets acquired	$	195	$	(7)	$	188

This acquisition did not meet the thresholds for a significant acquisition and therefore no pro forma financial information is presented.

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2020

Inventories

Major classes of inventory

	March 31,		December 31,		March 31,
	2020		2019		2019
Finished goods	$	884	$	872	$	868
Raw materials		121		128		126
Operating supplies		42		45		44
	$	1,047	$	1,045	$	1,038

XML

Restructuring Accruals (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring accrual
Beginning balance, restructuring reserve	$ 45	$ 69
Net cash paid, principally severance and related benefits	(8)	(15)
Other, including foreign exchange translation	(3)	(1)
Ending balance, restructuring reserve	34	53
Employee Costs
Restructuring accrual
Beginning balance, restructuring reserve	32	47
Net cash paid, principally severance and related benefits	(8)	(13)
Other, including foreign exchange translation	(2)
Ending balance, restructuring reserve	22	34
Other Exit Costs
Restructuring accrual
Beginning balance, restructuring reserve	13	22
Net cash paid, principally severance and related benefits		(2)
Other, including foreign exchange translation	(1)	(1)
Ending balance, restructuring reserve	$ 12	$ 19

XML

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Inventories
Finished goods	$ 884	$ 872	$ 868
Raw materials	121	128	126
Operating supplies	42	45	44
Inventories	$ 1,047	$ 1,045	$ 1,038

XML

CONSOLIDATED COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CONSOLIDATED COMPREHENSIVE INCOME
Net earnings	$ 55	$ 84
Other comprehensive income (loss):
Foreign currency translation adjustments	(573)	49
Pension and other postretirement benefit adjustments, net of tax	31	6
Change in fair value of derivative instruments, net of tax	6	5
Other comprehensive income (loss)	(536)	60
Total comprehensive income (loss)	(481)	144
Comprehensive (income) loss attributable to noncontrolling interests	4	(8)
Comprehensive income (loss) attributable to the Company	$ (477)	$ 136

XML

Segment Information

3 Months Ended

Mar. 31, 2020

Segment Information

Segment Information

1. Segment Information

The Company has three reportable segments and three operating segments based on its geographic locations: Americas, Europe and Asia Pacific. These three segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, and certain equity investments. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.

The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations, as well as certain retained corporate costs. The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under U.S. GAAP and therefore does not purport to be an alternative to earnings before income taxes. Further, the Company's measure of segment operating profit may not be comparable to similarly titled measures of other companies.
​

Financial information for the three months ended March 31, 2020 and 2019 regarding the Company’s reportable segments is as follows:

	Three months ended March 31,
	2020		2019
Net sales:
Americas	$	831	$	881
Europe		576		596
Asia Pacific		145		151
Reportable segment totals		1,552		1,628
Other		9		10
Net sales	$	1,561	$	1,638

	Three months ended March 31,
	2020		2019
Segment operating profit:
Americas	$	103	$	113
Europe		61		79
Asia Pacific		5		8
Reportable segment totals		169		200
Items excluded from segment operating profit:
Retained corporate costs and other		(21)		(24)
Charge for deconsolidation of Paddock		(14)
Interest expense, net		(53)		(65)
Earnings before income taxes	$	81	$	111

Financial information regarding the Company’s total assets is as follows:

	March 31,		December 31,		March 31,
	2020		2019		2019
Total assets:
Americas	$	4,693	$	5,264	$	5,621
Europe		3,290		3,127		3,273
Asia Pacific		896		1,012		1,012
Reportable segment totals		8,879		9,403		9,906
Other		625		207		246
Consolidated totals	$	9,504	$	9,610	$	10,152

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator:
Net earnings attributable to the Company	$ 50	$ 79
Denominator (in thousands):
Denominator for basic earnings per share - weighted average shares outstanding (in shares)	156,081,000	154,361,000
Effect of dilutive securities:
Stock options and other (in shares)	1,603,000	2,274,000
Denominator for diluted earnings per share - adjusted weighted average shares outstanding (in shares)	157,684,000	156,635,000
Basic earnings per share:
Net earnings attributable to the Company (in dollars per share)	$ 0.32	$ 0.51
Diluted earnings per share:
Net earnings attributable to the Company (in dollars per share)	$ 0.32	$ 0.51
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares)	2,533,717	1,496,298

XML

Business Combinations - Subsequent Adjustments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Jun. 28, 2019
Adjustment
Fair values of the assets and liabilities assumed
Goodwill	$ 18
Intangibles	(32)
Net property, plant, and equipment	32
Total assets acquired	18
Accounts payable	1
Accrued liabilities	(1)
Deferred tax liabilities	25
Net assets acquired	(7)
Nueva Fbrica Nacional de Vidrio, S. de R.L. de C.V. ("Nueva Fanal")
Fair values of the assets and liabilities assumed
Accounts receivable	42	$ 42
Inventory	17	17
Goodwill	18
Intangibles	3	35
Net property, plant, and equipment	161	129
Total assets acquired	241	223
Accounts payable	26	25
Accrued liabilities	2	3
Deferred tax liabilities	25
Net assets acquired	$ 188	$ 195

XML

Derivative Instruments

3 Months Ended

Mar. 31, 2020

Derivative Instruments

Derivative Instruments

5. Derivative Instruments

The Company has certain derivative assets and liabilities, which consist of natural gas forwards, foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Natural gas forward rates, foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs are observable in active markets over the terms of the instruments the Company holds, and, accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.

Commodity Forward Contracts Designated as Cash Flow Hedges

The Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows.

An unrecognized loss of $2 million at March 31, 2020, an unrecognized gain of $1 million at December 31, 2019 and an unrecognized gain of $3 million at March 31, 2019 related to the commodity forward contracts were included in Accumulated other comprehensive income (“Accumulated OCI”), and will be reclassified into earnings in the period when the commodity forward contracts expire.

Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments

The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies.

Cash Flow Hedges of Foreign Exchange Risk

The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency.  The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign exchange risk.

An unrecognized loss of $4 million at March 31, 2020, an unrecognized loss of less than $1 million at December 31, 2019 and an unrecognized loss of $11 million at March 31, 2019, related to these cross-currency swaps, were included in Accumulated OCI, and will be reclassified into earnings within the next twelve months.

Interest Rate Swaps Designated as Fair Value Hedges

The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. The Company’s fixed-to-variable interest rate swaps are accounted for as fair value hedges. The relevant terms of the swap agreements match the corresponding terms of the notes and therefore there is no hedge ineffectiveness. The Company recorded the net of the fair market values of the swaps as a long-term liability and short-term asset, along with a corresponding net decrease in the carrying value of the hedged debt.

Cash Flow Hedges of Interest Rate Risk

The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt.

An unrecognized loss of less than $1 million at March 31, 2020, an unrecognized loss of $1 million at December 31, 2019 and an unrecognized loss of less than $1 million at March 31, 2019 related to these interest rate swaps, were included in Accumulated OCI, and will be reclassified into earnings within the next twelve months.

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure.  

An unrecognized gain of $10 million at March 31, 2020, an unrecognized gain of $8 million at December 31, 2019 and an unrecognized gain of $7 million at March 31, 2019, related to these net investment hedges, were included in Accumulated OCI, and will be reclassified into earnings within the next twelve months.

Balance Sheet Classification

The following table shows the amount and classification (as noted above) of the Company’s derivatives at March 31, 2020, December 31, 2019 and March 31, 2019:

	Fair Value of						Fair Value of
	Hedge Assets						Hedge Liabilities
	March 31,		December 31,		March 31,		March 31,		December 31,		March 31,
	2020		2019		2019		2020		2019		2019
Derivatives designated as hedging instruments:
Commodity forward contracts (a)	$	—	$	1	$	3	$	2	$	—	$	—
Interest rate swaps - fair value hedges (b)		11		8		18				2
Cash flow hedges of foreign exchange risk (c)		66		25		18		4		21		4
Interest rate swaps - cash flow hedges (d)								2		1		1
Net investment hedges (e)		5		2		6						4
Total derivatives accounted for as hedges	$	82	$	36	$	45	$	8	$	24	$	9
Derivatives not designated as hedges:
Foreign exchange derivative contracts (f)		10		2		2		5		—		1
Total derivatives	$	92	$	38	$	47	$	13	$	24	$	10
Current	$	30	$	8	$	23	$	8	$	—	$	3
Noncurrent		62		30		24		5		24		7
Total derivatives	$	92	$	38	$	47	$	13	$	24	$	10

(a) The notional amounts of the commodity forward contracts were $12 million, $13 million and $20 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2020 for all three periods.

(b) The notional amounts of the interest rate swaps designated as fair value hedges were €725 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2025 for March 31, 2020 and December 31, 2019 and 2024 for March 31, 2019.

(c) The notional amounts of the cash flow hedges of foreign exchange risk were $1.424 billion at March 31, 2020 and December 31, 2019 and $797 million at March 31, 2019. The maximum maturity dates were in 2023 for all three periods.

(d) The notional amounts of the interest rate swaps designated as cash flow hedges were $105 million at March 31, 2020 and December 31, 2019 and $180 million at March 31, 2019, respectively. Maximum maturity dates were in 2020 for March 31, 2020 and December 31, 2019 and 2021 for March 31, 2019.

(e) The notional amounts of the net investment hedges were €160 million at March 31, 2020, December 31, 2019 and March 31, 2019. The maximum maturity dates were in 2020 for all three periods.

(f) The notional amounts of the foreign exchange derivative contracts were $306 million, $283 million and $625 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2021, 2019, and 2019 for March 31, 2020, December 31, 2019 and March 31, 2019, respectively.

	Gain (Loss) Recognized in OCI (Effective Portion)				Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1)
	Three months ended March 31,				Three months ended March 31,
Derivatives designated as hedging instruments:	2020		2019		2020		2019
Cash Flow Hedges
Commodity forward contracts (a)	$	(3)	$	2	$	—	$	—
Cash flow hedges of foreign exchange risk (b)		(66)		7		60		(10)
Cash flow hedges of interest rate risk (c)
Net Investment Hedges
Net Investment Hedges		(4)		5		2		(2)
	$	(73)	$	14	$	62	$	(12)
	Amount of Gain (Loss) Recognized in Other income (expense), net
	Three months ended March 31,
Derivatives not designated as hedges:	2020		2019
Foreign exchange derivative contracts	$	12	$	6
(1) Gains and losses reclassified from accumulated OCI and recognized in income are recorded to (a) cost of goods sold, (b) other expense, net or (c) interest expense, net.

XML

Debt

3 Months Ended

Mar. 31, 2020

Debt

Debt

9. Debt

The following table summarizes the long-term debt of the Company:

	March 31,		December 31,		March 31,
	2020		2019		2019
Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans	$	817	$	—	$	—
Term Loans:
Term Loan A		1,477		1,477
Previous Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans						553
Term Loans:
Term Loan A						897
Other secured debt		330		333		504
Senior Notes:
6.75%, due 2020 (€500 million)						560
4.875%, due 2021 (€118 million at March 31, 2020 and December 31, 2019 and €330 million at March 31, 2019)		130		132		369
5.00%, due 2022		497		497		497
4.00%, due 2023		307		307		307
5.875%, due 2023		689		689		688
3.125%, due 2024 (€725 million)		813		824		824
6.375%, due 2025		296		295		296
5.375%, due 2025		297		297		298
2.875%, due 2025 (€500 million)		543		552
Finance leases		84		70		43
Other		13		11		18
Total long-term debt		6,293		5,484		5,854
Less amounts due within one year		178		49		34
Long-term debt	$	6,115	$	5,435	$	5,820

The Company presents debt issuance costs in the balance sheet as a deduction of the carrying amount of the related debt liability.

On June 25, 2019, certain of the Company’s subsidiaries entered into a new Senior Secured Credit Facility Agreement (as amended by that certain Amendment No. 1 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 13, 2019, and as further amended by that certain Amendment No. 2 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 19, 2019, the “Agreement”), which amended and restated the previous credit agreement (the “Previous Agreement”). The proceeds from the Agreement were used to repay all outstanding amounts under the Previous Agreement.

The Agreement provides for up to $3.0 billion of borrowings pursuant to term loans and revolving credit facilities. The term loans mature, and the revolving credit facilities terminate, in June 2024. At March 31, 2020, the Agreement includes a $300 million revolving credit facility, a $1.2 billion multicurrency revolving credit facility, and a $1.5 billion term loan A facility ($1,477 million net of debt issuance costs). At March 31, 2020, the Company had unused credit of $673 million available under the Agreement. The weighted average interest rate on borrowings outstanding under the Agreement at March 31, 2020 was 2.28%.

The Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within

guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.

The Agreement also contains one financial maintenance covenant, a Total Leverage Ratio (the “Leverage Ratio”), that requires the Company not to exceed a ratio of 5.0x calculated by dividing consolidated total debt, less cash and cash equivalents, by Consolidated EBITDA, with such Leverage Ratio decreasing to (a) 4.75x for the quarter ending June 30, 2021 and (b) 4.50x for the quarter ending December 31, 2021 and thereafter, as defined and described in the Agreement. The maximum Leverage Ratio is subject to an increase of 0.5x for (i) any fiscal quarter during which certain qualifying acquisitions (as specified in the Agreement) are consummated and (ii) the following three fiscal quarters, provided that the Leverage Ratio shall not exceed 5.0x. The Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Leverage Ratio to exceed the specified maximum.

Failure to comply with these covenants and other customary restrictions could result in an event of default under the Agreement. In such an event, the Company could not request borrowings under the revolving facilities, and all amounts outstanding under the Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Agreement. If an event of default occurs under the Agreement and the lenders cause all of the outstanding debt obligations under the Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of March 31, 2020, the Company was in compliance with all covenants and restrictions in the Agreement.  In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Agreement will not be adversely affected by the covenants and restrictions.

The Leverage Ratio also determines pricing under the Agreement. The interest rate on borrowings under the Agreement is, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Agreement, plus an applicable margin. The applicable margin is linked to the Leverage Ratio. The margins range from 1.00% to 1.50% for Eurocurrency Loans and from 0.00% to 0.50% for Base Rate Loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Leverage Ratio.

Obligations under the Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Agreement are guaranteed by certain foreign subsidiaries of the Company.

In July 2019, the Company redeemed €250 million aggregate principal amount of its outstanding 6.75% senior notes due 2020. The redemption was funded with cash on hand and revolver borrowings.

In November 2019, the Company issued €500 million aggregate principal amount of new senior notes. The new senior notes bear interest at a rate of 2.875% per annum and mature on February 15, 2025. The new senior notes were issued via a private placement and are guaranteed by certain of the Company’s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately €492 million and were used to redeem the remaining €250 million aggregate principal amount of the Company’s outstanding 6.75% senior notes due 2020 and approximately €212 million aggregate principal amount of the Company’s outstanding 4.875% senior notes due 2021.

In December 2019, subsidiaries of the Company completed consent solicitations to amend and waive certain provisions of the indentures governing certain of their senior notes. On December 11, 2019, those subsidiaries entered into supplemental indentures reflecting the amendments and waivers, which were obtained to facilitate the implementation of the Corporate Modernization.

In order to maintain a capital structure containing appropriate amounts of fixed and floating-rate debt, the Company has entered into a series of interest rate swap agreements. These interest rate swap agreements were accounted for as either fair value hedges or cash flow hedges (see Note 5 for more information).

The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.

The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy. Fair values at March 31, 2020 of the Company’s significant fixed rate debt obligations are as follows:

	Principal		Indicated
	Amount		Market Price		Fair Value
Senior Notes:
4.875%, due 2021 (€118 million)		130		99.96		130
5.00%, due 2022		500		100.96		505
5.875%, due 2023		700		91.81		643
4.00%, due 2023		310		95.00		295
3.125%, due 2024 (€725 million)		798		94.82		757
6.375%, due 2025		300		88.71		266
5.375%, due 2025		300		94.91		285
2.875%, due 2025 (€500 million)		551		93.20		513

XML

Other Expense, net

3 Months Ended

Mar. 31, 2020

Other Expense, net

Other Expense, net

13. Other Expense, Net

Other expense (income), net for the three months ended March 31, 2020 and 2019 included the following:

	Three months ended March 31,
	2020		2019
Charge for deconsolidation of Paddock (see Note 10)	$	14	$	—
Foreign currency exchange loss				3
Intangible amortization expense		10		10
Royalty income		(4)		(3)
Other expense (income), net		(3)		—
	$	17	$	10

XML

Supplemental Cash Flow Information (Tables)

3 Months Ended

Mar. 31, 2020

Supplemental Cash Flow Information

Income taxes paid (received) in cash

	Three months ended March 31,
	2020		2019
U.S.	$	2	$	(7)
Non-U.S.		32		33
Total income taxes paid in cash	$	34	$	26

XML

Share Owners' Equity (Tables)

3 Months Ended

Mar. 31, 2020

Share Owners' Equity

Activity in share owner's equity

The activity in share owners’ equity for the three months ended March 31, 2020 and 2019 is as follows:

	Share Owners’ Equity of the Company
									Accumulated
			Capital in						Other		Non-		Total Share
	Common		Excess of		Treasury		Retained		Comprehensive		controlling		Owners'
	Stock		Par Value		Stock		Earnings (Loss)		Loss		Interests		Equity
Balance on January 1, 2020	$	2		3,130		(733)		(89)		(1,843)		97	$	564
Reissuance of common stock (0.2 million shares)				(3)		5								2
Stock compensation (0.8 million shares)				1										1
Net earnings								50				5		55
Other comprehensive loss										(527)		(9)		(536)
Dividends declared								(8)						(8)
Other						(2)								(2)
Balance on March 31, 2020	$	2	$	3,128	$	(730)	$	(47)	$	(2,370)	$	93	$	76

	Share Owners’ Equity of the Company
									Accumulated
			Capital in						Other		Non-		Total Share
	Common		Excess of		Treasury		Retained		Comprehensive		controlling		Owners'
	Stock		Par Value		Stock		Earnings		Loss		Interests		Equity
Balance on January 1, 2019	$	2		3,124		(705)		333		(1,968)		114	$	900
Reissuance of common stock (0.1 million shares)				2		3								5
Treasury shares purchased (2.1 million shares)						(38)								(38)
Stock compensation (0.5 million shares)				4										4
Net earnings								79				5		84
Other comprehensive income (loss)										57		3		60
Other						(5)								(5)
Balance on March 31, 2019	$	2	$	3,130	$	(745)	$	412	$	(1,911)	$	122	$	1,010

Schedule of shares outstanding

	Shares Outstanding (in thousands)
	March 31,	December 31,	March 31,
	2020	2019	2019
Shares of common stock issued (including treasury shares)	189,210	188,447	188,348
Treasury shares	32,639	32,573	33,117

XML

Restructuring Accruals (Tables)

3 Months Ended

Mar. 31, 2020

Restructuring

Selected information related to the restructuring accruals

Selected information related to the restructuring accruals for the three months ended March 31, 2020 and 2019 is as follows:

	Employee		Other		Total
	Costs		Exit Costs		Restructuring
Balance at January 1, 2020	$	32	$	13	$	45
Net cash paid, principally severance and related benefits		(8)				(8)
Other, including foreign exchange translation		(2)		(1)		(3)
Balance at March 31, 2020	$	22	$	12	$	34

	Employee		Other		Total
	Costs		Exit Costs		Restructuring
Balance at January 1, 2019	$	47	$	22	$	69
Net cash paid, principally severance and related benefits		(13)		(2)		(15)
Other, including foreign exchange translation				(1)		(1)
Balance at March 31, 2019	$	34	$	19	$	53

XML

Supplemental Cash Flow Information

3 Months Ended

Mar. 31, 2020

Supplemental Cash Flow Information

Supplemental Cash Flow Information

15. Supplemental Cash Flow Information

Income taxes paid (received) in cash were as follows:

	Three months ended March 31,
	2020		2019
U.S.	$	2	$	(7)
Non-U.S.		32		33
Total income taxes paid in cash	$	34	$	26

Interest paid in cash for the three months ended March 31, 2020 and 2019 was $58 million and $70 million, respectively.

The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. At March 31, 2020, December 31, 2019 and March 31, 2019, the amount of receivables sold by the Company was $429 million, $539 million and $303 million, respectively. For the three months ended March 31, 2020 and 2019, the Company reduced the use of its factoring programs compared to the most recent respective year-end periods and this resulted in a higher use of working capital, and corresponding decrease to cash from operating activities, of approximately $110 million and $297 million, respectively.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Information

Net sales for the Company's reportable segments

	Three months ended March 31,
	2020		2019
Net sales:
Americas	$	831	$	881
Europe		576		596
Asia Pacific		145		151
Reportable segment totals		1,552		1,628
Other		9		10
Net sales	$	1,561	$	1,638

Segment operating profit (loss) for the Company's reportable segments

	Three months ended March 31,
	2020		2019
Segment operating profit:
Americas	$	103	$	113
Europe		61		79
Asia Pacific		5		8
Reportable segment totals		169		200
Items excluded from segment operating profit:
Retained corporate costs and other		(21)		(24)
Charge for deconsolidation of Paddock		(14)
Interest expense, net		(53)		(65)
Earnings before income taxes	$	81	$	111

Total assets for the Company's reportable segments

	March 31,		December 31,		March 31,
	2020		2019		2019
Total assets:
Americas	$	4,693	$	5,264	$	5,621
Europe		3,290		3,127		3,273
Asia Pacific		896		1,012		1,012
Reportable segment totals		8,879		9,403		9,906
Other		625		207		246
Consolidated totals	$	9,504	$	9,610	$	10,152

XML

Derivative Instruments - Balance Sheet Classification (Details) € in Millions, $ in Millions	Mar. 31, 2020 EUR (€)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 EUR (€)	Dec. 31, 2019 USD ($)	Mar. 31, 2019 EUR (€)	Mar. 31, 2019 USD ($)
Derivatives, Fair Value
Total asset derivatives		$ 92		$ 38		$ 47
Total liability derivatives		13		24		10
Current derivative asset		30		8		23
Current derivative liability		8				3
Noncurrent derivative asset		62		30		24
Noncurrent derivative liability		5		24		7
Derivatives designated as hedging instruments
Derivatives, Fair Value
Total asset derivatives		82		36		45
Total liability derivatives		8		24		9
Derivatives designated as hedging instruments | Commodity forward contracts
Derivatives, Fair Value
Notional amount		12		13		20
Total asset derivatives				1		3
Total liability derivatives		2
Derivatives designated as hedging instruments | Interest rate swaps - fair value hedges
Derivatives, Fair Value
Notional amount | €	€ 725		€ 725		€ 725
Total asset derivatives		11		8		18
Total liability derivatives				2
Derivatives designated as hedging instruments | Interest rate swaps - cash flow hedges
Derivatives, Fair Value
Notional amount		105		105		180
Total liability derivatives		2		1		1
Derivatives designated as hedging instruments | Cash flow hedges of foreign exchange risk
Derivatives, Fair Value
Notional amount		1,424		1,424		797
Total asset derivatives		66		25		18
Total liability derivatives		4		21		4
Derivatives designated as hedging instruments | Net investment hedges
Derivatives, Fair Value
Notional amount | €	€ 160		€ 160
Total asset derivatives		5		2		6
Total liability derivatives						4
Derivatives not designated as hedging instruments | Foreign exchange contracts
Derivatives, Fair Value
Notional amount		306		283		625
Total asset derivatives		10		$ 2		2
Total liability derivatives		$ 5				$ 1

XML

Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue
Net sales	$ 1,561	$ 1,638
Reportable Segment Totals
Disaggregation of Revenue
Net sales	1,552	1,628
Americas
Disaggregation of Revenue
Net sales	831	881
Europe
Disaggregation of Revenue
Net sales	576	596
Asia Pacific
Disaggregation of Revenue
Net sales	145	151
Other
Disaggregation of Revenue
Net sales	9	10
Alcoholic beverages (beer, wine, spirits)
Disaggregation of Revenue
Net sales	1,020	1,105
Alcoholic beverages (beer, wine, spirits) | Americas
Disaggregation of Revenue
Net sales	508	564
Alcoholic beverages (beer, wine, spirits) | Europe
Disaggregation of Revenue
Net sales	411	432
Alcoholic beverages (beer, wine, spirits) | Asia Pacific
Disaggregation of Revenue
Net sales	101	109
Food and other
Disaggregation of Revenue
Net sales	318	308
Food and other | Americas
Disaggregation of Revenue
Net sales	189	180
Food and other | Europe
Disaggregation of Revenue
Net sales	105	103
Food and other | Asia Pacific
Disaggregation of Revenue
Net sales	24	25
Non-alcoholic beverages
Disaggregation of Revenue
Net sales	214	215
Non-alcoholic beverages | Americas
Disaggregation of Revenue
Net sales	134	137
Non-alcoholic beverages | Europe
Disaggregation of Revenue
Net sales	60	61
Non-alcoholic beverages | Asia Pacific
Disaggregation of Revenue
Net sales	$ 20	$ 17

XML

Debt (Details) $ / shares in Units, € in Millions, $ in Millions	1 Months Ended	3 Months Ended
	Nov. 30, 2019 EUR (€)	Mar. 31, 2020 USD ($) item agreement $ / shares	Dec. 31, 2021 item	Jun. 30, 2021 item	Mar. 31, 2020 EUR (€) item	Dec. 31, 2019 USD ($)	Dec. 31, 2019 EUR (€)	Jul. 31, 2019 EUR (€)	Mar. 31, 2019 USD ($)	Mar. 31, 2019 EUR (€)
Debt Instrument
Total long-term debt		$ 6,293				$ 5,484			$ 5,854
Less amounts due within one year		178				49			34
Long-term debt		$ 6,115				5,435			5,820
Number financial maintenance covenants | agreement		1
Maximum Leverage Ratio may increase | item		0.5
Short-term loans and long-term debt due within one year		$ 283				124			91
Maximum
Debt Instrument
Leverage Ratio | item		5.0			5.0
Maximum Borrowing Capacity		$ 3,000
Maximum | Forecast
Debt Instrument
Leverage Ratio | item			4.50	4.75
Secured Credit Agreement
Debt Instrument
Unused Credit		$ 673
Weighted average interest rate (as a percent)		2.28%			2.28%
Secured Credit Agreement | Minimum
Debt Instrument
Interest rate margin, Eurocurrency Rate loans (as a percent)		1.00%			1.00%
Interest rate margin, Base Rate loans (as a percent)		0.00%
Secured Credit Agreement | Maximum
Debt Instrument
Interest rate margin, Eurocurrency Rate loans (as a percent)		1.50%			1.50%
Interest rate margin, Base Rate loans (as a percent)		0.50%
Revolving Loans
Debt Instrument
Total long-term debt		$ 817
Revolving Loans | Prior Agreement
Debt Instrument
Total long-term debt									553
Term Loan A
Debt Instrument
Total long-term debt		1,477				1,477
Face Value		1,500
Net proceeds, after deducting debt issuance costs		1,477
Term Loan A | Prior Agreement
Debt Instrument
Total long-term debt									897
Other secured debt
Debt Instrument
Total long-term debt		$ 330				333			504
Senior Notes 6.75%, due 2020 (500 million EUR)
Debt Instrument
Total long-term debt					€ 500				560
Interest rate, stated percentage	6.75%	6.75%			6.75%			6.75%
Debt redeemed | €	€ 250							€ 250
Senior Notes 4.875%, due 2021 (118 million EUR at March 31, 2020, 118 million EUR at December 31, 2019 and 330 million EUR at March 31, 2019)
Debt Instrument
Total long-term debt		$ 130			€ 118	132	€ 118		369	€ 330
Interest rate, stated percentage	4.875%	4.875%			4.875%
Debt redeemed | €	€ 212
Fair values of fixed rate debt obligations
Principal Amount		$ 130
Indicated Market Price (in dollars per share) | $ / shares		$ 99.96
Fair Value		$ 130
Senior Notes 5.00%, due 2022
Debt Instrument
Total long-term debt		$ 497				497			497
Interest rate, stated percentage		5.00%			5.00%
Fair values of fixed rate debt obligations
Principal Amount		$ 500
Indicated Market Price (in dollars per share) | $ / shares		$ 100.96
Fair Value		$ 505
Senior Notes 4.00%, due 2023
Debt Instrument
Total long-term debt		$ 307				307			307
Interest rate, stated percentage		4.00%			4.00%
Fair values of fixed rate debt obligations
Principal Amount		$ 310
Indicated Market Price (in dollars per share) | $ / shares		$ 95.00
Fair Value		$ 295
Senior Notes 5.875%, due 2023
Debt Instrument
Total long-term debt		$ 689				689			688
Interest rate, stated percentage		5.875%			5.875%
Fair values of fixed rate debt obligations
Principal Amount		$ 700
Indicated Market Price (in dollars per share) | $ / shares		$ 91.81
Fair Value		$ 643
Senior Notes 3.125%, due 2024 (725 million EUR)
Debt Instrument
Total long-term debt		$ 813			€ 725	824	€ 725		824	€ 725
Interest rate, stated percentage		3.125%			3.125%
Fair values of fixed rate debt obligations
Principal Amount		$ 798
Indicated Market Price (in dollars per share) | $ / shares		$ 94.82
Fair Value		$ 757
Senior Notes 6.375%, due 2025
Debt Instrument
Total long-term debt		$ 296				295			296
Interest rate, stated percentage		6.375%			6.375%
Fair values of fixed rate debt obligations
Principal Amount		$ 300
Indicated Market Price (in dollars per share) | $ / shares		$ 88.71
Fair Value		$ 266
Senior Notes, 5.375% due 2025
Debt Instrument
Total long-term debt		$ 297				297			298
Interest rate, stated percentage		5.375%			5.375%
Fair values of fixed rate debt obligations
Principal Amount		$ 300
Indicated Market Price (in dollars per share) | $ / shares		$ 94.91
Fair Value		$ 285
Senior Notes 2.875%, due 2025 (500 million EUR)
Debt Instrument
Total long-term debt	€ 500	$ 543			€ 500	552
Interest rate, stated percentage	2.875%	2.875%			2.875%
Net proceeds, after deducting debt issuance costs | €	€ 492
Fair values of fixed rate debt obligations
Principal Amount		$ 551
Indicated Market Price (in dollars per share) | $ / shares		$ 93.20
Fair Value		$ 513
Finance leases
Debt Instrument
Total long-term debt		84				70			43
Other
Debt Instrument
Total long-term debt		13				$ 11			$ 18
Revolving Credit Facility
Debt Instrument
Total long-term debt		$ 300
Additional default interest rate per annum applied to all obligations owed under the Agreement		2.00%
Revolving Credit Facility | Minimum
Debt Instrument
Facility fee payable (as a percent)		0.20%
Revolving Credit Facility | Maximum
Debt Instrument
Facility fee payable (as a percent)		0.30%
Multicurrency Revolving Credit Facility
Debt Instrument
Total long-term debt		$ 1,200

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2020 shares
Cover page.
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2020
Entity File Number	1-9576
Entity Registrant Name	O-I GLASS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-2781933
Entity Address, Address Line One	One Michael Owens Way
Entity Address, City or Town	Perrysburg
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43551
City Area Code	567
Local Phone Number	336-5000
Title of 12(b) Security	Common Stock, $.01 par value
Security Exchange Name	NYSE
Trading Symbol	OI
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	156,571,353
Entity Central Index Key	0000812074
Amendment Flag	false
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
CONSOLIDATED BALANCE SHEETS
Trade receivables allowance	$ 30	$ 32	$ 34

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Other comprehensive income (loss)	$ (536)	$ 60
Net Effect of Exchange Rate Fluctuations
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(813)	(889)
Change before reclassifications	(564)	46
Other comprehensive income (loss)	(564)	46
Balance at end of the period	(1,377)	(843)
Change in Certain Derivative Instruments
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(14)	(18)
Change before reclassifications	(2)	(2)
Amounts reclassified from accumulated other comprehensive income	11	3
Translation effect	(1)	2
Tax effect	(2)	2
Other comprehensive income (loss)	6	5
Balance at end of the period	(8)	(13)
Employee Benefit Plans
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(1,016)	(1,061)
Change before reclassifications	(2)	(2)
Amounts reclassified from accumulated other comprehensive income	17	13
Translation effect	16	(5)
Other comprehensive income (loss)	31	6
Balance at end of the period	(985)	(1,055)
Accumulated Other Comprehensive Loss.
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	(1,843)	(1,968)
Change before reclassifications	(568)	42
Amounts reclassified from accumulated other comprehensive income	28	16
Translation effect	15	(3)
Tax effect	(2)	2
Other comprehensive income (loss)	(527)	57
Balance at end of the period	$ (2,370)	$ (1,911)

XML

New Accounting Pronouncement (Details)	Mar. 31, 2020 USD ($)
ASU 2016-13 Financial Instruments - Credit Losses
Cumulative effect	$ 0

XML

Credit Losses

3 Months Ended

Mar. 31, 2020

Credit losses

Credit Losses

3. Credit Losses

The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers that it sells them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue recovery of defaulted receivables.

At March 31, 2020, the Company reported $767 million of accounts receivable, net of allowances of $30 million. Changes in the allowance were not material for the three months ended March 31, 2020.

XML

Other Expense, net (Tables)

3 Months Ended

Mar. 31, 2020

Other Expense, net

Schedule of other expense (income), net

	Three months ended March 31,
	2020		2019
Charge for deconsolidation of Paddock (see Note 10)	$	14	$	—
Foreign currency exchange loss				3
Intangible amortization expense		10		10
Royalty income		(4)		(3)
Other expense (income), net		(3)		—
	$	17	$	10

XML

Pension Benefit Plans (Tables)

3 Months Ended

Mar. 31, 2020

Pension Benefit Plans

Defined Benefit Plans and Other Postretirement Benefit Plans

Components of net periodic pension cost

The components of the net periodic pension cost for the three months ended March 31, 2020 and 2019 are as follows:

	U.S.				Non-U.S.
	2020		2019		2020		2019
Service cost	$	3	$	3	$	3	$	3
Interest cost		12		15		7		8
Expected asset return		(21)		(22)		(12)		(12)
Amortization of actuarial loss		14		10		3		3
Net periodic pension cost	$	8	$	6	$	1	$	2

XML

Segment Information - Reportable Segments (Details) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020 USD ($) segment	Mar. 31, 2019 USD ($)	Dec. 31, 2019 USD ($)
Segment Reporting Information
Number of reportable segments | segment	3
Number of operating segments | segment	3
Net sales:
Net sales	$ 1,561	$ 1,638
Segment operating profit:
Segment operating profit	169	200
Items excluded from segment operating profit:
Retained corporate costs and other charges	(21)	(24)
Charge for deconsolidation of Paddock	(14)
Charge for asbestos related costs			$ (35)
Interest expense, net	(53)	(65)
Earnings from continuing operations before income taxes
Earnings before income taxes	81	111
Reportable Segment Totals
Net sales:
Net sales	1,552	1,628
Americas
Net sales:
Net sales	831	881
Segment operating profit:
Segment operating profit	103	113
Europe
Net sales:
Net sales	576	596
Segment operating profit:
Segment operating profit	61	79
Asia Pacific
Net sales:
Net sales	145	151
Segment operating profit:
Segment operating profit	5	8
Other
Net sales:
Net sales	$ 9	$ 10

XML

Pension Benefit Plans

3 Months Ended

Mar. 31, 2020

Pension Benefit Plans and Other Postretirement Benefits

Pension Benefit Plans and Other Postretirement Benefits

7. Pension Benefit Plans

The components of the net periodic pension cost for the three months ended March 31, 2020 and 2019 are as follows:

	U.S.				Non-U.S.
	2020		2019		2020		2019
Service cost	$	3	$	3	$	3	$	3
Interest cost		12		15		7		8
Expected asset return		(21)		(22)		(12)		(12)
Amortization of actuarial loss		14		10		3		3
Net periodic pension cost	$	8	$	6	$	1	$	2

XML

Share Owners' Equity

3 Months Ended

Mar. 31, 2020

Share Owners' Equity

Share Owners' Equity

11. Share Owners’ Equity

The activity in share owners’ equity for the three months ended March 31, 2020 and 2019 is as follows:

	Share Owners’ Equity of the Company
									Accumulated
			Capital in						Other		Non-		Total Share
	Common		Excess of		Treasury		Retained		Comprehensive		controlling		Owners'
	Stock		Par Value		Stock		Earnings (Loss)		Loss		Interests		Equity
Balance on January 1, 2020	$	2		3,130		(733)		(89)		(1,843)		97	$	564
Reissuance of common stock (0.2 million shares)				(3)		5								2
Stock compensation (0.8 million shares)				1										1
Net earnings								50				5		55
Other comprehensive loss										(527)		(9)		(536)
Dividends declared								(8)						(8)
Other						(2)								(2)
Balance on March 31, 2020	$	2	$	3,128	$	(730)	$	(47)	$	(2,370)	$	93	$	76

	Share Owners’ Equity of the Company
									Accumulated
			Capital in						Other		Non-		Total Share
	Common		Excess of		Treasury		Retained		Comprehensive		controlling		Owners'
	Stock		Par Value		Stock		Earnings		Loss		Interests		Equity
Balance on January 1, 2019	$	2		3,124		(705)		333		(1,968)		114	$	900
Reissuance of common stock (0.1 million shares)				2		3								5
Treasury shares purchased (2.1 million shares)						(38)								(38)
Stock compensation (0.5 million shares)				4										4
Net earnings								79				5		84
Other comprehensive income (loss)										57		3		60
Other						(5)								(5)
Balance on March 31, 2019	$	2	$	3,130	$	(745)	$	412	$	(1,911)	$	122	$	1,010

The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:

	Shares Outstanding (in thousands)
	March 31,	December 31,	March 31,
	2020	2019	2019
Shares of common stock issued (including treasury shares)	189,210	188,447	188,348
Treasury shares	32,639	32,573	33,117

XML

Share Owners' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Increase (Decrease) in Share Owners' Equity
Balance	$ 564	$ 900
Reissuance of common stock	$ 2	$ 5
Reissuance of common stock (in shares)	200,000	100,000
Treasury shares purchased		$ (38)
Treasury shares purchased (in shares)		2,100,000
Stock compensation	$ 1	$ 4
Stock compensation (in shares)	800,000	500,000
Net earnings	$ 55	$ 84
Other comprehensive income (loss)	(536)	60
Dividends declared	(8)
Other	(2)	(5)
Balance	$ 76	$ 1,010
Authorization of common stock
Common stock, shares authorized	250,000,000
Common stock, par value (in dollars per share)	$ 0.01
Shares of common stock issued (including treasury shares)	189,210,000	188,348,000	188,447,000
Treasury stock, shares	32,639,000	33,117,000	32,573,000
Common Stock
Increase (Decrease) in Share Owners' Equity
Balance	$ 2	$ 2
Balance	2	2
Capital in Excess of Par Value
Increase (Decrease) in Share Owners' Equity
Balance	3,130	3,124
Reissuance of common stock	(3)	2
Stock compensation	1	4
Balance	3,128	3,130
Treasury Stock
Increase (Decrease) in Share Owners' Equity
Balance	(733)	(705)
Reissuance of common stock	5	3
Treasury shares purchased		(38)
Other	(2)	(5)
Balance	(730)	(745)
Retained Earnings (accumulated deficit)
Increase (Decrease) in Share Owners' Equity
Balance	(89)	333
Net earnings	50	79
Dividends declared	(8)
Balance	(47)	412
Accumulated Other Comprehensive Loss.
Increase (Decrease) in Share Owners' Equity
Balance	(1,843)	(1,968)
Other comprehensive income (loss)	(527)	57
Balance	(2,370)	(1,911)
Non-controlling Interests
Increase (Decrease) in Share Owners' Equity
Balance	97	114
Net earnings	5	5
Other comprehensive income (loss)	(9)	3
Balance	$ 93	$ 122

XML

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Income taxes paid	$ 34	$ 26
Interest paid in cash	58	70
Amount of receivables sold	429	303	$ 539
Change in cash from operating activities from factoring program	110	297
U.S.
Income taxes paid	2	(7)
Non-U.S.
Income taxes paid	$ 32	$ 33

XML

Revenue

3 Months Ended

Mar. 31, 2020

Revenue

Revenue

2. Revenue

Revenue is recognized at the point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Sales, value added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment.

For the three-month periods ended March 31, 2020 and March 31, 2019, the Company had no material bad debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Condensed Consolidated Balance Sheet. For the three-month periods ended March 31, 2020 and March 31, 2019, revenue recognized from prior periods (for example, due to changes in transaction price) was not material.

The following tables for the three months ended March 31, 2020 and 2019 disaggregates the Company’s revenue by customer end use:

	Three months ended March 31, 2020
	Americas		Europe		Asia Pacific		Total
Alcoholic beverages (beer, wine, spirits)	$	508	$	411	$	101	$	1,020
Food and other		189		105		24		318
Non-alcoholic beverages		134		60		20		214
Reportable segment totals	$	831	$	576	$	145	$	1,552
Other								9
Net sales							$	1,561
	Three months ended March 31, 2019
	Americas		Europe		Asia Pacific		Total
Alcoholic beverages (beer, wine, spirits)	$	564	$	432	$	109	$	1,105
Food and other		180		103		25		308
Non-alcoholic beverages		137		61		17		215
Reportable segment totals	$	881	$	596	$	151	$	1,628
Other								10
Net sales							$	1,638

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Current assets:
Cash and cash equivalents	$ 891	$ 551	$ 326
Trade receivables, net of allowances of $30 million, $32 million, and $34 million at March 31, 2020, December 31, 2019, and March 31, 2019	767	621	939
Inventories	1,047	1,045	1,038
Prepaid expenses and other current assets	257	271	276
Total current assets	2,962	2,488	2,579
Property, plant and equipment, net	2,987	3,273	3,074
Goodwill	1,773	1,934	2,507
Intangibles, net	312	371	394
Other assets	1,470	1,544	1,598
Total assets	9,504	9,610	10,152
Current liabilities:
Accounts payable	1,025	1,276	1,065
Short-term loans and long-term debt due within one year	283	124	91
Current portion of asbestos-related liabilities			160
Other liabilities	516	595	544
Total current liabilities	1,824	1,995	1,860
Long-term debt	6,115	5,435	5,820
Asbestos-related liabilities		486	372
Paddock support agreement liability	471
Other long-term liabilities	1,018	1,130	1,090
Share owners' equity	76	564	1,010
Total liabilities and share owners' equity	$ 9,504	$ 9,610	$ 10,152

XML

Segment Information - Total Assets (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Assets
Total assets:	$ 9,504	$ 9,610	$ 10,152
Reportable Segment Totals
Assets
Total assets:	8,879	9,403	9,906
Americas
Assets
Total assets:	4,693	5,264	5,621
Europe
Assets
Total assets:	3,290	3,127	3,273
Asia Pacific
Assets
Total assets:	896	1,012	1,012
Other
Assets
Total assets:	$ 625	$ 207	$ 246

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share

Computation of basic and diluted earnings per share

	Three months ended March 31,
	2020		2019
Numerator:
Net earnings attributable to the Company	$	50	$	79
Denominator (in thousands):
Denominator for basic earnings per share-weighted average shares outstanding		156,081		154,361
Effect of dilutive securities:
Stock options and other		1,603		2,274
Denominator for diluted earnings per share-adjusted weighted average shares outstanding		157,684		156,635
Basic earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51
Diluted earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2020

Debt

Long-term Debt

	March 31,		December 31,		March 31,
	2020		2019		2019
Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans	$	817	$	—	$	—
Term Loans:
Term Loan A		1,477		1,477
Previous Secured Credit Agreement:
Revolving Credit Facility:
Revolving Loans						553
Term Loans:
Term Loan A						897
Other secured debt		330		333		504
Senior Notes:
6.75%, due 2020 (€500 million)						560
4.875%, due 2021 (€118 million at March 31, 2020 and December 31, 2019 and €330 million at March 31, 2019)		130		132		369
5.00%, due 2022		497		497		497
4.00%, due 2023		307		307		307
5.875%, due 2023		689		689		688
3.125%, due 2024 (€725 million)		813		824		824
6.375%, due 2025		296		295		296
5.375%, due 2025		297		297		298
2.875%, due 2025 (€500 million)		543		552
Finance leases		84		70		43
Other		13		11		18
Total long-term debt		6,293		5,484		5,854
Less amounts due within one year		178		49		34
Long-term debt	$	6,115	$	5,435	$	5,820

Fair values of the Company's significant fixed rate debt obligations

	Principal		Indicated
	Amount		Market Price		Fair Value
Senior Notes:
4.875%, due 2021 (€118 million)		130		99.96		130
5.00%, due 2022		500		100.96		505
5.875%, due 2023		700		91.81		643
4.00%, due 2023		310		95.00		295
3.125%, due 2024 (€725 million)		798		94.82		757
6.375%, due 2025		300		88.71		266
5.375%, due 2025		300		94.91		285
2.875%, due 2025 (€500 million)		551		93.20		513

XML

Restructuring Accruals

3 Months Ended

Mar. 31, 2020

Restructuring

Restructuring

6. Restructuring Accruals

Selected information related to the restructuring accruals for the three months ended March 31, 2020 and 2019 is as follows:

	Employee		Other		Total
	Costs		Exit Costs		Restructuring
Balance at January 1, 2020	$	32	$	13	$	45
Net cash paid, principally severance and related benefits		(8)				(8)
Other, including foreign exchange translation		(2)		(1)		(3)
Balance at March 31, 2020	$	22	$	12	$	34

	Employee		Other		Total
	Costs		Exit Costs		Restructuring
Balance at January 1, 2019	$	47	$	22	$	69
Net cash paid, principally severance and related benefits		(13)		(2)		(15)
Other, including foreign exchange translation				(1)		(1)
Balance at March 31, 2019	$	34	$	19	$	53

When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the on-going operations of the business. Information related to major programs is presented separately while minor initiatives are presented on a combined basis. As of March 31, 2020 and 2019, no major restructuring programs were in effect.

For the three months ended March 31, 2020 and 2019, the Company has paid severance and related benefits along with other exit costs that were associated with past restructuring actions. The Company expects that the majority of the

remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years.

XML

Contingencies

3 Months Ended

Mar. 31, 2020

Contingencies

Contingencies

10. Contingencies

Asbestos

From 1948 to 1958, one of the Company's former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos. The Company sold its insulation business unit in April 1958. The Company historically received claims from individuals alleging bodily injury and death as a result of exposure to asbestos from this product (“Asbestos Claims”). Some Asbestos Claims were brought as personal injury lawsuits that typically allege various theories of liability, including negligence, gross negligence and strict liability and seek compensatory and, in some cases, punitive damages.

Predominantly, however, Asbestos Claims were historically presented to the Company under administrative claims-handling agreements, which the Company had in place with many plaintiffs’ counsel throughout the country (“Administrative Claims”). Administrative Claims required evaluation and negotiation regarding whether particular claimants qualify under the criteria established by the related claims-handling agreements. The criteria for Administrative Claims included verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company's former business unit during its manufacturing period ending in 1958. Plaintiffs’ counsel presented, and the Company negotiated, Administrative Claims under these various agreements in differing quantities, at different times, and under a variety of conditions.

On December 26 and 27, 2019, the Company implemented the Corporate Modernization (“Corporate Modernization”), whereby O-I Glass became the new parent entity with Owens-Illinois Group, Inc. (“O-I Group”) and Paddock Enterprises, LLC (“Paddock”) as direct, wholly owned subsidiaries, with Paddock as the successor-by-merger to O-I. The Company’s legacy asbestos-related liabilities remained within Paddock, structurally separating them from the Company’s glass-making operations, which remain under O-I Group.

On January 6, 2020 (the “Petition Date”), Paddock voluntarily filed for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware to equitably and finally resolve all of its current and future asbestos-related claims. O-I Glass and O-I Group were not included in the Chapter 11 filing. As a result of the initiation of the Chapter 11 proceeding, Paddock now operates in the ordinary course under court protection from asbestos claims by operation of the automatic stay in Paddock’s Chapter 11 filing, which stays ongoing litigation and submission of claims against Paddock as of the Petition Date and defers the payment of Paddock’s outstanding

obligations on account of settled or otherwise determined lawsuits and claims. The bankruptcy process is expected to provide a centralized forum to resolve presently pending and anticipated future lawsuits and claims associated with asbestos. Paddock’s ultimate goal in its Chapter 11 case is to confirm a plan of reorganization under Section 524(g) of the Bankruptcy Code and utilize this specialized provision to establish a trust that will address all current and future asbestos-related claims. Because the Chapter 11 proceedings are in the early stages, it is not possible to predict the form of the ultimate resolution or when an ultimate resolution might occur.

As part of the Corporate Modernization transactions, O-I Glass entered into a support agreement with Paddock that requires O-I Glass to provide funding to Paddock for all permitted uses, subject to the terms of the support agreement. The key objectives of the support agreement are to ensure that Paddock has the ability to fund the costs and expenses of managing the Chapter 11 process, ultimately settle Asbestos Claims through the establishment of a trust as described above and fund certain other liabilities including applicable taxes. The ultimate amount that may be required to fund the trust in connection with a confirmed Chapter 11 plan of reorganization cannot be estimated with certainty.

Following the Chapter 11 filing, the activities of Paddock are now subject to review and oversight by the bankruptcy court. As a result, the Company no longer has exclusive control over Paddock’s activities during the Chapter 11 proceedings. Therefore, Paddock was deconsolidated as of the Petition Date, and its assets and liabilities, which primarily included $47 million of cash, the legacy asbestos-related liabilities, as well as certain other assets and liabilities, were derecognized from the Company’s consolidated financial statements on a prospective basis. Simultaneously, the Company recognized a liability related to the support agreement, as described above, of $471 million as required under applicable accounting standards, which may be subject to change based on the facts and circumstances of the Chapter 11 proceedings. Taken together, these transactions resulted in a loss of approximately $14 million, which was reflected as a charge in the Company’s first quarter 2020 operating results. Additionally, the deconsolidation resulted in an investing outflow of $47 million in the Company’s first quarter 2020 consolidated cash flows.

Several risks and uncertainties related to Paddock’s Chapter 11 case could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows, including the ultimate amounts necessary to fund any trust established pursuant to Section 524(g) of the Bankruptcy Code, the potential for the Company’s asbestos-related exposure to extend beyond Paddock based on corporate veil piercing efforts or other claims by asbestos plaintiffs, the costs of the Chapter 11 proceedings and the length of time necessary to resolve the case, either through settlement or various court proceedings, and the possibility that Paddock will be unsuccessful in attaining the desired relief under Chapter 11.

Prior to the Petition Date, the Company knew of approximately 850 asbestos lawsuits pending. This figure does not include an estimate of potential Administrative Claims that could have been presented under a claims-handling agreement due to the uncertainties around presentation timing, quantities, or qualification rates. The Company historically considered Administrative Claims to be filed and disposed of when they are accepted for payment.

The lack of uniform rules in lawsuit pleading practice, technical pleading requirement in some jurisdictions, local rules, and other factors caused considerable variation in the specific amounts of monetary damages asserted in lawsuits brought prior to the Petition Date. In the Company’s experience, the monetary relief alleged in a lawsuit bore little relationship to an Asbestos Claim’s merits or its disposition value. Rather, several variables, including but not limited to, the type and severity of the asbestos disease, medical history, and exposure to other disease-causing agents; the product identification evidence against the Company and other co-defendants; the defenses available to the Company and other co-defendants; the specific jurisdiction in which the claim was made; the applicable law; and the law firm representing the claimant, affected the value.

The Company was also a defendant in other Asbestos Claims involving maritime workers, medical monitoring, co-defendants’ third-party actions, and property damage allegations. Based upon its experience, the Company assessed that these categories of Asbestos Claims would not involve any material liability. Therefore, they were not included in the description of pending or disposed matters.

From receipt of its first Asbestos Claim to the Petition Date, the Company in the aggregate disposed of approximately 401,200 Asbestos Claims at an average indemnity payment of approximately $10,200 per claim. The Company’s asbestos indemnity payments varied on a per-claim basis. Asbestos-related cash payments for 2019 were $151 million and the Company’s cash payments per claim disposed (inclusive of legal costs) were approximately $129,000 for the year ended December 31, 2019.

Prior to the Petition Date, the Company’s objective was historically to achieve, where possible, resolution of Asbestos Claims pursuant to claims-handling agreements. Failure of claimants to meet certain medical and product exposure criteria in claims-handling agreements generally reduced the number of claims that would otherwise have been received by the Company in the tort system. In addition, changes in jurisdictional dynamics, legislative acts, asbestos docket management and procedures, the substantive law, the co-defendant pool, and other external factors affected lawsuit volume, claim volume, qualification rates, claim values, and related matters. Collectively, these variables generally had the effect of increasing the Company’s per-claim average indemnity payment over time.

Beginning with the initial liability of $975 million established in 1993, the Company accrued a total of approximately $5.0 billion through just prior to the Petition Date, before insurance recoveries, for its asbestos-related liability. The Company’s estimates of its liability were significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that filed for bankruptcy, changes in mortality rates, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the significant expansion of the types of defendants sued in this litigation, and changes in the extent to which such defendants participated in the resolution of cases in which the Company was also a defendant.

Prior to the Petition Date, the Company continually monitored trends that could affect its ultimate liability and analyzed the developments and variables likely to affect the resolution of Asbestos Claims. The material components of the Company’s total accrued liability were determined by the Company in connection with its annual comprehensive legal review and consisted of the following estimates, to the extent it was probable that such liabilities had been incurred and could be reasonably estimated: (i) the liability for Asbestos Claims already asserted against the Company; (ii) the liability for Asbestos Claims not yet asserted against the Company; and (iii) the legal defense costs estimated to be incurred in connection with the Asbestos Claims already asserted and those Asbestos Claims the Company believed would be asserted.

Through December 31, 2019, the Company historically conducted an annual comprehensive legal review of its asbestos-related liabilities and costs in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments have warranted an earlier review. As part of its annual comprehensive legal review, the Company provided historical Asbestos Claims data to a third party with expertise in determining the impact of disease incidence and mortality on future filing trends to develop information to assist the Company in estimating the total number of future Asbestos Claims likely to be asserted against the Company. The Company used this estimate, along with an estimation of disposition costs and related legal costs, as inputs to develop its best estimate of its total probable liability. If the results of the annual comprehensive legal review indicated that the existing amount of the accrued liability was lower (higher) than its reasonably estimable asbestos-related costs, then the Company recorded an appropriate charge (credit) to the Company’s results of operations to increase (decrease) the accrued liability.

The significant assumptions underlying the material components of the Company’s accrual historically were:

a) settlements would continue to be limited almost exclusively to claimants who were exposed to the Company’s asbestos containing insulation prior to its exit from that business in 1958;

b) Asbestos Claims would continue to be resolved primarily under the Company’s administrative claims-handling agreements or on terms comparable to those set forth in those agreements;

c) the incidence of serious asbestos-related disease cases and claiming patterns against the Company for such cases would not change materially, including claiming pattern changes driven by changes in the law, procedure, or expansion of judicial resources in jurisdictions where the Company settles Asbestos Claims;

d) the Company would be substantially able to defend itself successfully at trial and on appeal;

e) the number and timing of additional co-defendant bankruptcies would not change significantly the assets available to participate in the resolution of cases in which the Company is a defendant; and

f) co-defendants with substantial resources and assets would continue to participate significantly in the resolution of future Asbestos Claims.

For the year ended December 31, 2019, the Company concluded that an accrual in the amount of $486 million was required under applicable accounting standards. This amount has not been discounted for the time value of money. The Company’s comprehensive legal review resulted in a charge of $35 million the year ended December 31, 2019. As

previously disclosed, the Company anticipated that adjustments to its asbestos-related accruals were possible given the inherent uncertainties involved in asbestos litigation. In the fourth quarter of 2019, this charge was primarily due to an increase in the estimated average disposition cost per claim (including related legal costs), driven primarily by a changing litigation environment more favorable to plaintiffs, and an decrease in the estimated number of claims likely to be asserted against the Company in the future that was less than the decrease expected by the company.

Other Matters

Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2020

Earnings Per Share

Earnings Per Share

14. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:

	Three months ended March 31,
	2020		2019
Numerator:
Net earnings attributable to the Company	$	50	$	79
Denominator (in thousands):
Denominator for basic earnings per share-weighted average shares outstanding		156,081		154,361
Effect of dilutive securities:
Stock options and other		1,603		2,274
Denominator for diluted earnings per share-adjusted weighted average shares outstanding		157,684		156,635
Basic earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51
Diluted earnings per share:
Net earnings attributable to the Company	$	0.32	$	0.51

Options to purchase 2,533,717 and 1,496,298 weighted average shares of common stock, which were outstanding during the three months March 31, 2020 and 2019, respectively, were not included in the computation of diluted earnings per share because the options exercise price was greater than the average market price of the common shares.

XML

COVID-19 Impacts

3 Months Ended

Mar. 31, 2020

COVID-19 Impacts

COVID-19 Impacts

18. COVID-19 Impacts

On March 11, 2020, the World Health Organization characterized the outbreak of the coronavirus disease, known as COVID-19, as a global pandemic and recommended containment and mitigation measures. The Company is actively monitoring the impact of the coronavirus global pandemic, which will negatively impact its business and results of operations for the second quarter of 2020 and likely beyond.  The extent to which the Company’s operations will be impacted by the global pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the global pandemic and actions by government authorities to contain the global pandemic or treat its impact, among other things.

Future changes in the Company’s cost of capital, expected cash flows, or other factors as a result of the above may cause the Company’s long-lived assets including goodwill to be impaired, resulting in a non-cash charge against results of operations to write down long-lived assets including goodwill for the amount of the impairment.

XML

Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2020

Derivative Instruments

Balance Sheet Classification of derivative instruments

	Fair Value of						Fair Value of
	Hedge Assets						Hedge Liabilities
	March 31,		December 31,		March 31,		March 31,		December 31,		March 31,
	2020		2019		2019		2020		2019		2019
Derivatives designated as hedging instruments:
Commodity forward contracts (a)	$	—	$	1	$	3	$	2	$	—	$	—
Interest rate swaps - fair value hedges (b)		11		8		18				2
Cash flow hedges of foreign exchange risk (c)		66		25		18		4		21		4
Interest rate swaps - cash flow hedges (d)								2		1		1
Net investment hedges (e)		5		2		6						4
Total derivatives accounted for as hedges	$	82	$	36	$	45	$	8	$	24	$	9
Derivatives not designated as hedges:
Foreign exchange derivative contracts (f)		10		2		2		5		—		1
Total derivatives	$	92	$	38	$	47	$	13	$	24	$	10
Current	$	30	$	8	$	23	$	8	$	—	$	3
Noncurrent		62		30		24		5		24		7
Total derivatives	$	92	$	38	$	47	$	13	$	24	$	10

(a) The notional amounts of the commodity forward contracts were $12 million, $13 million and $20 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2020 for all three periods.

(b) The notional amounts of the interest rate swaps designated as fair value hedges were €725 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2025 for March 31, 2020 and December 31, 2019 and 2024 for March 31, 2019.

(c) The notional amounts of the cash flow hedges of foreign exchange risk were $1.424 billion at March 31, 2020 and December 31, 2019 and $797 million at March 31, 2019. The maximum maturity dates were in 2023 for all three periods.

(d) The notional amounts of the interest rate swaps designated as cash flow hedges were $105 million at March 31, 2020 and December 31, 2019 and $180 million at March 31, 2019, respectively. Maximum maturity dates were in 2020 for March 31, 2020 and December 31, 2019 and 2021 for March 31, 2019.

(e) The notional amounts of the net investment hedges were €160 million at March 31, 2020, December 31, 2019 and March 31, 2019. The maximum maturity dates were in 2020 for all three periods.

(f) The notional amounts of the foreign exchange derivative contracts were $306 million, $283 million and $625 million at March 31, 2020, December 31, 2019 and March 31, 2019, respectively. The maximum maturity dates were in 2021, 2019, and 2019 for March 31, 2020, December 31, 2019 and March 31, 2019, respectively.

Effects of derivative instruments on the results of operations

	Gain (Loss) Recognized in OCI (Effective Portion)				Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1)
	Three months ended March 31,				Three months ended March 31,
Derivatives designated as hedging instruments:	2020		2019		2020		2019
Cash Flow Hedges
Commodity forward contracts (a)	$	(3)	$	2	$	—	$	—
Cash flow hedges of foreign exchange risk (b)		(66)		7		60		(10)
Cash flow hedges of interest rate risk (c)
Net Investment Hedges
Net Investment Hedges		(4)		5		2		(2)
	$	(73)	$	14	$	62	$	(12)
	Amount of Gain (Loss) Recognized in Other income (expense), net
	Three months ended March 31,
Derivatives not designated as hedges:	2020		2019
Foreign exchange derivative contracts	$	12	$	6
(1) Gains and losses reclassified from accumulated OCI and recognized in income are recorded to (a) cost of goods sold, (b) other expense, net or (c) interest expense, net.

XML

Contingencies - Asbestos (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2020 USD ($) lawsuit	Dec. 31, 2019 USD ($)	Jan. 06, 2020 USD ($)	Dec. 31, 1993 USD ($)
Loss contingencies
Sale of goods containing asbestos from 1948 to 1958	$ 40,000,000
Liability From Deconsolidation	471,000,000
Charge for deconsolidation of Paddock	(14,000,000)
Deconsolidation investing outflow	$ 47,000,000
Approximate number of claims disposed | lawsuit	401,200
Number of pending plaintiffs and claimants | lawsuit	850
Average indemnity payment per claim	$ 10,200
Asbestos-related cash payments		$ 151,000,000
Cash payments per claim disposed including legal costs		129,000
Asbestos-related liability, total amount accrued beginning in 1993 through current reporting period before insurance recoveries	5,000,000,000.0			$ 975,000,000
Accrual of asbestos related liability		486,000,000
Asbestos related charges		$ 35,000,000
Paddock
Loss contingencies
Cash			$ 47,000,000
Liability From Deconsolidation			$ 471,000,000
Charge for deconsolidation of Paddock	(14,000,000)
Deconsolidation investing outflow	$ 47,000,000

XML

Derivative Instruments - Effects of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivatives not designated as hedging instruments | Foreign exchange contracts
Derivatives and Hedges
Amount of Gain (Loss) Recognized in Other income (expense), net	$ 12	$ 6
Derivatives designated as hedging instruments
Derivatives and Hedges
Gain (Loss) Recognized in OCI (Effective Portion)	(73)	14
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	62	(12)
Derivatives designated as hedging instruments | Net Investment Hedges
Derivatives and Hedges
Gain (Loss) Recognized in OCI (Effective Portion)	(4)	5
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	2	(2)
Derivatives designated as hedging instruments | Commodity forward contracts | Cash Flow Hedges | Cost of goods sold
Derivatives and Hedges
Gain (Loss) Recognized in OCI (Effective Portion)	(3)	2
Derivatives designated as hedging instruments | Foreign exchange risk | Cash Flow Hedges | Other expense, net
Derivatives and Hedges
Gain (Loss) Recognized in OCI (Effective Portion)	(66)	7
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	$ 60	$ (10)

XML

Credit Losses (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Credit losses
Accounts receivable, net	$ 767	$ 621	$ 939
Allowance for doubtful accounts	$ 30	$ 32	$ 34